Unnamed: 0,title,date,stock,sentiment
1221660.0,"Shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some US states that have reopened, leading to concerns of a second wave of the virus.",2020-06-11 10:22:00-04:00,TEVA,positive
1221661.0,Interim Results Of U.K. Trial Of Hydroxychloroquine Show No Evidence Of Benefit In Hospitalized COVID-19 Patients,2020-06-05 09:41:00-04:00,TEVA,positive
1221662.0,"Hydroxychloroquine No Better Than Placebo In Preventing Infection With The Conroavirus, University Of Minnesota Study Shows",2020-06-03 15:26:00-04:00,TEVA,positive
1221663.0,"Shares Of Mylan, Teva Ticking Lower As Dow Jones Reports 'Antimalaria Drug Didn't Protect Against Covid-19 In Latest Large Study'",2020-06-03 15:03:00-04:00,TEVA,negative
1221664.0,'Antimalaria Drug Didn't Protect Against Covid-19 In Latest Large Study',2020-06-03 15:02:00-04:00,TEVA,negative
1221665.0,'WHO says hydroxychloroquine coronavirus trials to resume' -AFP Tweet,2020-06-03 12:14:00-04:00,TEVA,neutral
1221666.0,UPDATE: Lancet Editors Say Important Scientific Questions Have Been Raised About Data Reported In The Paper,2020-06-02 15:49:00-04:00,TEVA,positive
1221667.0,Lancet Editors Say They Are Issuing Expression Of Concern About Paper 'hydroxychloroquine Or Chloroquine With Or Without A Macrolide For Treatment Of Covid-19: A Multinational Registry Analysis',2020-06-02 15:49:00-04:00,TEVA,neutral
1221668.0,"Benzinga's Top Upgrades, Downgrades For June 1, 2020",2020-06-01 09:42:00-04:00,TEVA,positive
1221669.0,10 Biggest Price Target Changes For Monday,2020-06-01 08:21:00-04:00,TEVA,neutral
1221670.0,"SunTrust Robinson Humphrey Upgrades Teva Pharmaceutical Indus to Buy, Raises Price Target of $16",2020-06-01 06:19:00-04:00,TEVA,neutral
1221671.0,"Cramer Shares His Thoughts On Teva, Oxford Industries And More",2020-05-29 06:40:00-04:00,TEVA,positive
1221672.0,U.K. Agency Says Hydroxychloroquine Trial Paused,2020-05-27 11:45:00-04:00,TEVA,neutral
1221673.0,"UPDATE: After World Health Organization Halted Hydroxychloroquine Arm Of Solidarity Trial Says Decision On Harm, Benefit Or Lack Of Benefit Will Be Made After Safety Board's Review Due To Be Completed By Mid June",2020-05-26 11:01:00-04:00,TEVA,positive
1221674.0,"World Health Organization Says Expects Safety Panel To Conduct Review Of Hydroxychloroquine In COVID-19 Patients By Mid-June, Plans To Include Data From Its Solidarity Trial, Other Trials In Review",2020-05-26 11:00:00-04:00,TEVA,positive
1221675.0,"WHO Halts Use of Hydroxychloroquine,, Chloroquine in Solidarity Trials for Covid-19 Due to Concerns; Says Remain Useful for Malaria",2020-05-25 12:43:00-04:00,TEVA,positive
1221676.0,President Trump Says He's No Longer Taking Hydroxychloroquine,2020-05-25 12:41:00-04:00,TEVA,negative
1221677.0,Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY  Experience in Populations with Difficult-to-Treat Migraine,2020-05-25 11:01:00-04:00,TEVA,neutral
1221678.0,"WHO's Ryan Says Current Guidance For Hydroxychloroquine Does Not Support Widespread Use For Covid-19 Until Trials Are Complete, Notes Brazil Has Approved Wider Use",2020-05-22 11:50:00-04:00,TEVA,positive
1221679.0,"Letter To Senator Schumer, VA Secretary Wilkie Says They Have Administered Hydroxychloroquine To ~1,300 COVID Patients -Frank Throp Tweet (Full Letter)",2020-05-22 11:01:00-04:00,TEVA,neutral
1221680.0,"'Antimalarial drug touted by President Trump is linked to increased risk of death in coronavirus patients, study says' -Breaking Washington Post Report",2020-05-22 08:40:00-04:00,TEVA,negative
1221681.0,"Comments On Hydroxychloroquine Reportedly Published In The Lancet, Study Finds Increased Mortality Linked To Hydroxychloroquine",2020-05-22 08:39:00-04:00,TEVA,positive
1221682.0,"Brazil Health Ministry Recommends Chloroquine, Hydroxychloroquine to Treat Even Mild Covid-19 Cases, Despite Lack of Conclusive Evidence of Effectiveness",2020-05-20 09:30:00-04:00,TEVA,positive
1221683.0,Trump Says He Thinks Hydroxychloroquine Gives You An Additional Level Of Safety,2020-05-19 14:09:00-04:00,TEVA,positive
1221684.0,Teva Canada Secures Salbutamol Inhalers From Its Global Supply Chain To Mitigate Shortage In Canadian Market,2020-05-19 08:22:00-04:00,TEVA,positive
1221685.0,Teva Pharmaceuticals Industries shares are higher the company announced the Chinese approval of Austedo for treatment of Chorea associated with Huntington's Disease and Tardive Dyskinesia.,2020-05-18 09:25:00-04:00,TEVA,positive
1221686.0,Teva Pharma Announces Chinese Approval of Austedo for Treatement of Chorea Associated with Huntington's Disease and Tardive Dyskinesia in Adults,2020-05-18 07:02:00-04:00,TEVA,positive
1221687.0,13F From Buffett's Berkshire Shows Cut Stake In Teva By ~400K Shares,2020-05-15 16:30:00-04:00,TEVA,neutral
1221688.0,US National Institutes For Health Begins Trial Of Hydroxychloroquine And Azithromycin As Coronavirus Treatment,2020-05-14 14:07:00-04:00,TEVA,neutral
1221689.0,"New York Ag Says Will Issue New Subpoenas To Multiple Banks, Financial Institutions To Determine Where The Sacklers Stored Their Money Over The Years",2020-05-13 15:58:00-04:00,TEVA,neutral
1221690.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,TEVA,negative
1221691.0,"UBS Maintains Buy on Teva Pharmaceutical Indus, Raises Price Target to $15",2020-05-11 10:08:00-04:00,TEVA,neutral
1221692.0,Senator Schumer Called on Veterans Affairs Administration to Come Clean on Whether It's Using Veterans to Test Hydroxychloroquine,2020-05-10 17:11:00-04:00,TEVA,positive
1221693.0,"SVB Leerink Maintains Market Perform on Teva Pharmaceutical Indus, Raises Price Target to $12",2020-05-08 13:05:00-04:00,TEVA,neutral
1221694.0,"Teva Pharmaceutical Indus Option Alert: Jan, 2022 $25 Calls Sweep (8) near the Ask: 300 @ $0.824 vs 776 OI; Ref=$11.548",2020-05-08 09:35:00-04:00,TEVA,positive
1221695.0,"B of A Securities Reiterates Underperform on Teva Pharmaceutical Indus, Raises Price Target to $8",2020-05-08 09:25:00-04:00,TEVA,positive
1221696.0,"Teva CEO Kare Schultz On Drugmaker's Outlook, Coronavirus Response",2020-05-07 14:52:00-04:00,TEVA,neutral
1221697.0,Teva Pharmaceutical Industries shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-05-07 07:08:00-04:00,TEVA,positive
1221698.0,"Teva Reaffirms FY20 Guidance: EPS $2.30-$2.55, EBITDA $4.5B-$4.9B, Net Sales $16.6B-$17B",2020-05-07 07:00:00-04:00,TEVA,neutral
1221699.0,"Teva Pharmaceutical Indus Q1 Adj. EPS $0.760 Beats $0.590 Estimate, Sales $4.400B Beat $4.150B Estimate",2020-05-07 07:00:00-04:00,TEVA,neutral
1221700.0,"Earnings Scheduled For May 7, 2020",2020-05-07 05:02:00-04:00,TEVA,neutral
1221701.0,Shares of several healthcare companies are trading higher amid positive investor sentiment as some US states begin to reopen their economies and as oil prices gain for the session.,2020-05-05 12:44:00-04:00,TEVA,positive
1221702.0,"Teva, Celltrion Report Launch Of TRUXIMA Injection For Rehumatoid Arthritis",2020-05-04 08:02:00-04:00,TEVA,neutral
1221703.0,Shares of several healthcare companies are trading lower as markets dip following recent strength. Markets have sold off as investors weigh recent earnings and amid concerns of renewed US-China trade frictions.,2020-05-01 12:35:00-04:00,TEVA,positive
1221704.0,"Teva Highlights New Data For AJOVY Injection, AUSTEDO Tablets Included In Neurology",2020-05-01 08:03:00-04:00,TEVA,neutral
1221705.0,Teva Reports Teva Canada Launched AJOVY For Preventive Treatment of Migraine in Adults Who Have at Least Four Migraine Days Per Month,2020-04-29 08:09:00-04:00,TEVA,positive
1221706.0,UPDATE: Court In Eagle Pharma Case Upheld Asserted Patent Claims As Valid And Found That The Defendants' Proposed ANDA Products Would Infringe Claims,2020-04-28 06:55:00-04:00,TEVA,neutral
1221707.0,"Court Issues Patent Litigation Decision For Eagle Pharmaceuticals, Inc. And Teva Pharmaceutical Industries Ltd. For BENDEKA (bendamustine hydrochloride injection)",2020-04-28 06:53:00-04:00,TEVA,negative
1221708.0,Teva Highlights US Launch Of Autoinjector For AJOVY Injection,2020-04-27 08:05:00-04:00,TEVA,neutral
1221709.0,US Virus Treatment Guidelines Reject Trump-Backed Drug Combo; NIH Recommends Against Malaria Drug,2020-04-21 13:42:00-04:00,TEVA,negative
1221710.0,"NY Gov. Cuomo: 20 Hospitals In State Will Send First Tranche Of Results On Hydroxychloroquine Study To FDA, CDC Today",2020-04-20 12:15:00-04:00,TEVA,neutral
1221711.0,"Piper Sandler Maintains Neutral on Teva Pharmaceutical Indus, Lowers Price Target to $8",2020-04-15 08:58:00-04:00,TEVA,negative
1221712.0,Shares of several healthcare companies are trading higher amid overall market strength after the US Federal Reserve announced a further $2.3 trillion in financing programs to support the economy. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic and US Senator Sanders exiting the Presidential race.,2020-04-09 09:58:00-04:00,TEVA,positive
1221713.0,Shares of several healthcare companies are trading higher amid optimism that coronavirus cases in Asia are potentially easing. Global slowing cases could raise hopes of a sooner return to spending and economic activity. Several companies in the sector may also be benefiting from increased demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-07 07:48:00-04:00,TEVA,positive
1221714.0,Teva Analyst Says Shares Are Pricing In Too Much Risk,2020-04-06 11:37:00-04:00,TEVA,neutral
1221715.0,Teva Pharmaceuticals shares are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. UBS also upgraded the company's stock from Neutral to Buy.,2020-04-06 11:37:00-04:00,TEVA,positive
1221716.0,"Benzinga's Top Upgrades, Downgrades For April 6, 2020",2020-04-06 09:31:00-04:00,TEVA,positive
1221717.0,"UBS Upgrades Teva Pharmaceutical Indus to Buy, Lowers Price Target to $12",2020-04-06 08:49:00-04:00,TEVA,negative
1221718.0,16 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-04-06 07:46:00-04:00,TEVA,neutral
1221719.0,U.S. Emergency Management Official Says Working to Push Out Millions of Doses of Hydroxychloroquine,2020-04-05 19:31:00-04:00,TEVA,negative
1221720.0,Trump Says Will Ask Doctors if he Should Take Anti-malarial Drug to Treat Coronavirus,2020-04-04 17:20:00-04:00,TEVA,positive
1221721.0,Trump Says 29M Doses of Anti-malarial Drugs Will Be Put in Strategic National Stockpile for Coronavirus Patients,2020-04-04 16:59:00-04:00,TEVA,neutral
1221723.0,"Morgan Stanley Maintains Underweight on Teva Pharmaceutical Indus, Lowers Price Target to $8",2020-04-02 09:26:00-04:00,TEVA,negative
1221724.0,Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.,2020-04-01 09:20:00-04:00,TEVA,negative
1221725.0,Teva Pharmaceutical Indus Option Alert: Fri $9 Calls Sweep (32) near the Ask: 675 @ $0.388 vs 3486 OI; Earnings 4/30 Before Open [est] Ref=$9.04,2020-03-31 14:33:00-04:00,TEVA,positive
1221726.0,Patent Court Rejects Eli Lilly Challenge To Teva Patents On Migraine Drug Ajovy,2020-03-31 13:11:00-04:00,TEVA,negative
1221727.0,"Shares of several healthcare companies are trading higher amid market strength. NOTE: The coronavirus pandemic has potentially benefited the sector due to demand for medical supplies, testing and treatment candidates",2020-03-31 12:00:00-04:00,TEVA,positive
1221728.0,"Amarin Analysts React To Vascepa Patent Loss, See Small Chance Of Overturning Judgment",2020-03-31 10:53:00-04:00,TEVA,negative
1221729.0,17 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-03-31 07:58:00-04:00,TEVA,neutral
1221730.0,Shares of several healthcare companies are trading higher as the market rebounds on extended measures to help curb the coronavirus. NOTE: The sector could also be trading higher due to increased demand for medical products amid the coronavirus outbreak.,2020-03-30 10:17:00-04:00,TEVA,positive
1221731.0,'Chloroquine Use For COVID-19 Coronavirus Shows No Benefit In First Small—But Limited—Controlled Trial' -Earlier Forbes Article,2020-03-25 12:03:00-04:00,TEVA,positive
1221732.0,"Teva Pharmaceuticals shares are trading lower, not currently seeing company-specific news. Movement appears market related as equities experience volatility amid US stimulus progress.",2020-03-25 11:49:00-04:00,TEVA,positive
1221733.0,"Benzinga Pro's Stock To Watch For Wed., Mar. 25, 2020: AMRX",2020-03-25 08:16:00-04:00,TEVA,neutral
1221734.0,"Chloroquine, Hydroxychloroquine And Coronavirus: What You Should Know",2020-03-24 17:16:00-04:00,TEVA,neutral
1221735.0,"B of A Securities Maintains Underperform on Teva Pharmaceutical Indus, Lowers Price Target to $7",2020-03-23 08:49:00-04:00,TEVA,positive
1221736.0,Why Teva's Stock Is Trading Higher Today,2020-03-20 11:35:00-04:00,TEVA,neutral
1221737.0,Teva Pharmaceutical Industrial shares are trading higher after the company announced it would donate 6M doses of potential COVID-19 treatment with Hydroxychloroquine Sulfate tablets to hospitals nationwide.,2020-03-20 09:48:00-04:00,TEVA,positive
1221738.0,"Benzinga Pro's Stock To Watch For Fri., Mar. 20, 2020: TEVA",2020-03-20 08:00:00-04:00,TEVA,neutral
1221739.0,"Teva to Donate 6M Doses of Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide",2020-03-20 05:34:00-04:00,TEVA,neutral
1221740.0,US President Trump Says U.S Ordered A Lot Of Chloroquine To Treat Coronavirus,2020-03-19 15:13:00-04:00,TEVA,positive
1221741.0,"Teva Shares Spike To Session High, Up 4%, As Trump Discusses Melaria Treatment Hydroxychloroquine, Sold Under Brand Name Plaquenil (Among Others) By Teva As Potential Treatment For Coronavirus",2020-03-19 11:46:00-04:00,TEVA,positive
1221742.0,"Shares of several healthcare companies are trading higher, rebounding from Monday's crash. Stocks may also potentially be getting a boost from expectations of further stimulus proposals.",2020-03-17 09:10:00-04:00,TEVA,positive
1221743.0,Teva And Celltrion Healthcare Announce US Availability Of HERZUMA For Injection,2020-03-16 08:05:00-04:00,TEVA,neutral
1221744.0,Shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.,2020-03-12 09:26:00-04:00,TEVA,negative
1221745.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,TEVA,negative
1221746.0,Shares of several healthcare companies are trading higher as markets rebound following Monday's selloff. US President Trump on Monday indicated the US may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak.,2020-03-10 07:54:00-04:00,TEVA,positive
1221747.0,Shares of several healthcare  companies are trading lower. Movement appears market-related as markets continue to dip amid the global coronavirus outbreak and OPEC failing to reach production agreement.,2020-03-09 10:55:00-04:00,TEVA,neutral
1221748.0,52 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-09 08:04:00-04:00,TEVA,neutral
1221749.0,Shares of several healthcare companies are trading lower. Movement appears market related as markets continue to dip amid the global coronavirus outbreak.,2020-03-06 09:11:00-05:00,TEVA,neutral
1221750.0,23 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-03-06 07:56:00-05:00,TEVA,neutral
1221751.0,"Wells Fargo Maintains Equal-Weight on Teva Pharmaceutical Indus, Raises Price Target to $12",2020-03-05 09:23:00-05:00,TEVA,positive
1221752.0,Shares of several drugmakers and healthcare companies are trading higher following US Super Tuesday results in which Joe Biden won the highest number of delegates. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:48:00-05:00,TEVA,positive
1221753.0,"The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More",2020-03-03 07:51:00-05:00,TEVA,positive
1221754.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,2020-02-28 09:06:00-05:00,TEVA,negative
1221755.0,Shares of several healthcare companies are trading lower as growing coronavirus fears hamper economic outlook.,2020-02-27 09:28:00-05:00,TEVA,negative
1221756.0,"Teva shares are trading higher. Strength potentially related to opioid settlement announcement from Mallinckrodt, as Teva has also been involved in opioid litigation.",2020-02-25 08:37:00-05:00,TEVA,positive
1221757.0,Teva Pharmaceutical shares are trading lower. Weakness potentially related to fears of the coronavirus spread in Israel as well as peer Mallinckrodt reportedly being in bankruptcy talks with creditors.,2020-02-24 15:29:00-05:00,TEVA,negative
1221758.0,Teva Announces FDA Approval of ArmonAir Digihaler Inhalation Powder,2020-02-24 08:01:00-05:00,TEVA,positive
1221759.0,22 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-02-20 07:56:00-05:00,TEVA,neutral
1221760.0,50 Stocks Moving in Thursday's Pre-Market Session,2020-02-20 07:30:00-05:00,TEVA,neutral
1221761.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,TEVA,negative
1221762.0,Teva Pharmaceutical Indus shares are trading higher. Not seeing any company-specific news to justify the price action.,2020-02-19 10:02:00-05:00,TEVA,positive
1221763.0,"Opiant Pharmaceuticals Inc On February 12, 2020, Plaintiffs And Perrigo Entered Into A Settlement Agreement To Resolve Certain Ongoing Litigation",2020-02-18 08:53:00-05:00,TEVA,positive
1221764.0,10 Biggest Price Target Changes For Tuesday,2020-02-18 08:35:00-05:00,TEVA,neutral
1221765.0,"Argus Research Maintains Buy on Teva Pharmaceutical Indus, Raises Price Target to $15",2020-02-18 07:49:00-05:00,TEVA,neutral
1221766.0,CA Ag's Office Says 'Far Along In The Process Of Talks' And Still Negotiating With Distributors On Opioid Settlement,2020-02-14 12:24:00-05:00,TEVA,neutral
1221767.0,Shares of opioid-related companies are trading lower following reports suggesting 21 states have rejected an $18 billion offer to settle opioid litigation.,2020-02-14 10:15:00-05:00,TEVA,negative
1221768.0,21 States Reject $18B Offer From Drug Wholesalers To Settle Opioid Litigation,2020-02-14 10:10:00-05:00,TEVA,negative
1221769.0,"Morgan Stanley Maintains Underweight on Teva Pharmaceutical Indus, Raises Price Target to $13",2020-02-14 09:17:00-05:00,TEVA,neutral
1221770.0,3 Analysts Dissect Teva's Q4 Results,2020-02-13 13:31:00-05:00,TEVA,neutral
1221771.0,"B of A Securities Maintains Underperform on Teva Pharmaceutical Indus, Raises Price Target to $11",2020-02-13 11:40:00-05:00,TEVA,positive
1221772.0,Teva shares are trading lower in a potential selloff following Wednesday's strength. Shares were strong on Wednesday after the company reported better-than-expected Q4 EPS and sales results.,2020-02-13 10:05:00-05:00,TEVA,positive
1221773.0,"SunTrust Robinson Humphrey Maintains Hold on Teva Pharmaceutical Indus, Raises Price Target to $13",2020-02-13 09:22:00-05:00,TEVA,neutral
1221774.0,10 Biggest Price Target Changes For Thursday,2020-02-13 08:13:00-05:00,TEVA,neutral
1221775.0,"Oppenheimer Maintains Outperform on Teva Pharmaceutical Indus, Raises Price Target to $16",2020-02-13 07:36:00-05:00,TEVA,neutral
1221776.0,60 Biggest Movers From Yesterday,2020-02-13 05:45:00-05:00,TEVA,neutral
1221777.0,"Cantor Fitzgerald Maintains Neutral on Teva Pharmaceutical Indus, Raises Price Target to $15",2020-02-12 14:08:00-05:00,TEVA,neutral
1221778.0,"CFRA Maintains Hold on Teva Pharmaceutical Indus, Raises Price Target to $13",2020-02-12 13:50:00-05:00,TEVA,neutral
1221779.0,52 Stocks Moving In Wednesday's Mid-Day Session,2020-02-12 12:13:00-05:00,TEVA,neutral
1221780.0,Teva CEO Schultz Says Still Working On Previously-Negotiated Opioid Settlement,2020-02-12 08:38:00-05:00,TEVA,neutral
1221781.0,Teva Pharm CFO Says Expects Europe And North American Generics To Be Relatively Stable In 2020,2020-02-12 08:36:00-05:00,TEVA,positive
1221782.0,Teva Pharmaceuticals Industries shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.,2020-02-12 08:35:00-05:00,TEVA,positive
1221783.0,From Teva Earnings Conference Call: Sees Trial Results For Tourette Syndrome Candidate In Q1'20,2020-02-12 08:21:00-05:00,TEVA,neutral
1221784.0,Teva  CEO Schultz Says Expects Further Debt Refinancing In 2022 Similar To 2019 Refinancing,2020-02-12 08:15:00-05:00,TEVA,negative
1221785.0,Teva Reports Q4 Earnings Beat,2020-02-12 07:56:00-05:00,TEVA,neutral
1221786.0,31 Stocks Moving in Wednesday's Pre-Market Session,2020-02-12 07:15:00-05:00,TEVA,neutral
1221787.0,"Teva Sees FY20 Adj. EPS $2.30-$2.55 vs $2.47 Est., Sales $16.6B-$17B vs $17.18B Est.",2020-02-12 07:04:00-05:00,TEVA,neutral
1221788.0,"Teva Pharmaceutical Indus Q4 Adj. EPS $0.64 Beats $0.61 Estimate, Sales $4.5B Beat $4.35B Estimate",2020-02-12 07:03:00-05:00,TEVA,neutral
1221789.0,"Earnings Scheduled For February 12, 2020",2020-02-12 04:22:00-05:00,TEVA,neutral
1221790.0,"Teva Pharmaceutical Indus Option Alert: Jan, 2021 $18 Calls Sweep (25) near the Ask: 1231 @ $1.0 vs 18785 OI; Earnings 2/12 Before Open Ref=$12.63",2020-02-11 14:31:00-05:00,TEVA,positive
1221791.0,Q4 Earnings Outlook For Teva,2020-02-11 13:13:00-05:00,TEVA,neutral
1221792.0,"New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofA",2020-02-10 14:43:00-05:00,TEVA,negative
1221793.0,Here's How Much Investing $100 In Allergan Stock Back In 2010 Would Be Worth Today,2020-02-10 11:48:00-05:00,TEVA,positive
1221794.0,Shares of healthcare companies are trading higher amid a rebound in global equities following last week's selloff on coronavirus fears.,2020-02-04 10:08:00-05:00,TEVA,negative
1221795.0,Teva Pharmaceuticals shares are trading higher after the company announced positive top-line results from AJOVY clinical trials in Japan.,2020-02-03 10:59:00-05:00,TEVA,positive
1221796.0,Teva Announces Positive Top-Line Results from AJOVY Clinical Trials in Japan,2020-02-03 05:12:00-05:00,TEVA,positive
1221797.0,Teva Pharmaceuticals shares are trading higher after the company announced it received FDA approval for its AJOVY autoinjector.,2020-01-29 09:56:00-05:00,TEVA,positive
1221798.0,"The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut",2020-01-29 08:30:00-05:00,TEVA,neutral
1221799.0,30 Stocks Moving in Wednesday's Pre-Market Session,2020-01-29 07:15:00-05:00,TEVA,neutral
1221800.0,Teva Announces FDA Approval Of AJOVY Injection Autoinjector,2020-01-28 16:07:00-05:00,TEVA,positive
1221801.0,"Shares of several companies in the healthcare and pharmaceutical space are trading lower, not currently seeing sector-specific news. NOTE: The global spread of the Wuhan coronavirus has caused equities across to sell off.",2020-01-24 11:40:00-05:00,TEVA,neutral
1221802.0,"Teva Pharmaceuticals shares are trading higher. Wells Fargo analysts raised their price target from $8 to $10. Additionally, Allergan and Ironwood earlier announced a settlement with the company resolving the LINZESS patent litigation.",2020-01-22 13:30:00-05:00,TEVA,positive
1221803.0,"Wells Fargo Maintains Equal-Weight on Teva Pharmaceutical Indus, Raises Price Target to $10",2020-01-22 09:59:00-05:00,TEVA,positive
1221804.0,"Ironwood And Allergan Announce Settlement With Teva Resolving LINZESS Patent Litigation; Settlement Does Not Grant License To Teva With Regard To 72 mcg Generic Version Of LINZESS, Grants Teva License To Market 145 mcg And 290 mcg Generics Starting 2029",2020-01-22 09:27:00-05:00,TEVA,positive
1221805.0,Teva Pharmaceuticals shares are trading lower. Not seeing any news to justify the price action.,2020-01-17 11:22:00-05:00,TEVA,neutral
1221806.0,Teva shares are trading higher. Not currently seeing any company-specific news. NOTE: The company on Monday presented at the JP Morgan healthcare conference where it provided updates and company outlook.,2020-01-15 11:04:00-05:00,TEVA,positive
1221807.0,80 Biggest Movers From Yesterday,2020-01-15 04:48:00-05:00,TEVA,neutral
1221808.0,Teva shares are trading higher. The company yesterday presented at the JP Morgan healthcare conference where it provided updates and company outlook.,2020-01-14 11:36:00-05:00,TEVA,positive
1221809.0,Foresees A Stable Positive Outlook For U.S. Generics And Biosimilars,2020-01-13 14:22:00-05:00,TEVA,positive
1221810.0,Teva At JPM Conf. Says It Expects Low Revenue Growth In 2020 Due To The Drug From Copaxone,2020-01-13 13:55:00-05:00,TEVA,positive
1221811.0,Teva At JPM Healthcare Conf. Says Debt Is Now Approaching $25 Bln And Our Strategy Is To Continue To Reduce Debt,2020-01-13 13:45:00-05:00,TEVA,negative
1221812.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-01-06 07:38:00-05:00,TEVA,neutral
1221813.0,Teva Pharmaceuticals shares are trading lower in sympathy with the overall market after a U.S. airstrike killed Iranian Major-General Qasem Soleimani.,2020-01-03 11:39:00-05:00,TEVA,negative
1221814.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2020",2020-01-03 11:33:00-05:00,TEVA,positive
1221815.0,34 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-03 07:45:00-05:00,TEVA,neutral
1221816.0,16 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-12-23 07:50:00-05:00,TEVA,neutral
1221817.0,Shares of healthcare companies are trading higher on reports suggesting Congress will permanently repeal three major Obamacare-related health industry taxes as part of fiscal 2020 spending bills.,2019-12-16 12:48:00-05:00,TEVA,positive
1221818.0,Teva Pharmaceuticals Industries shares are trading lower. Not seeing any company-specific news to justify the price action.,2019-12-10 14:16:00-05:00,TEVA,neutral
1221819.0,41 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-10 08:10:00-05:00,TEVA,neutral
1221820.0,38 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-12-09 08:26:00-05:00,TEVA,neutral
1221821.0,Teva Pharmaceuticals shares are trading lower. Not currently seeing any company-specific news.,2019-12-05 11:11:00-05:00,TEVA,neutral
1221822.0,Teva Pharmaceuticals shares are trading higher on a rebound after many opioid-related drug manufacturers traded lower on reports federal prosecutors opened a criminal probe. The company responded saying the probe was previously disclosed in Q3 filings.,2019-11-27 10:20:00-05:00,TEVA,negative
1221823.0,Pharma Companies Shares Tank As Feds Investigate Opioid Crisis,2019-11-27 06:14:00-05:00,TEVA,negative
1221824.0,"Teva, In Response To Report On Probe Of Opioid Makers, Distributors, Says Subpoena Referenced On Nov. 26 Was Previously Disclosed In Q3 Public Filings",2019-11-26 16:27:00-05:00,TEVA,neutral
1221825.0,Meg Tirrell On CNBC Says Opioid Investigation Is Not New,2019-11-26 14:20:00-05:00,TEVA,neutral
1221826.0,Shares of opioid-related drugmakers are trading lower on reports federal prosecutors have opened a criminal probe of opioid manufacturers.,2019-11-26 13:08:00-05:00,TEVA,negative
1221827.0,Teva Pharmaceuticals shares are trading higher after the company announced tender offers to purchase for cash up to $1.5 billion in 3 senior notes.,2019-11-25 09:23:00-05:00,TEVA,positive
1221828.0,36 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-11-25 08:40:00-05:00,TEVA,neutral
1221829.0,Teva Pharma Reports Early Tender Results To Purchase For Cash Up To $1.5B In 3 Senior Notes,2019-11-25 08:08:00-05:00,TEVA,neutral
1221830.0,"Corcept Therapeutics Shares Fall As Hearing Teva Patent Trial Against Co.'s '214 Korlym Has Been Instituted By Patent Trial, Appeal Board As Patent Claims Determined to Be Likely Invalid",2019-11-20 15:16:00-05:00,TEVA,positive
1221831.0,"Health Canada Says For Past Several Weeks, Apotex, Astrazeneca Canada And Teva Canada Have Reported Tamoxifen Shortages On Drug Shortages Canada Website; Reasons Included Unexpected Manufacturing Disruptions & Increased Demand",2019-11-20 14:07:00-05:00,TEVA,negative
1221832.0,Teva shares are trading higher. Not currently seeing any company-specific news.,2019-11-19 10:23:00-05:00,TEVA,positive
1221833.0,Shares of several healthcare companies are trading higher after President Trump discussed transparency around pricing & processing in the healthcare industry,2019-11-15 14:51:00-05:00,TEVA,positive
1221834.0,Teva Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2019-11-15 11:45:00-05:00,TEVA,positive
1221835.0,Teva Pharmaceutical Industries shares are trading lower on a potential sell-off after the stock rallied approximately 39% over the past month.,2019-11-14 12:22:00-05:00,TEVA,neutral
1221836.0,Teva Pharmaceutical Indus Option Alert: Mar 20 $9 Puts at the Ask: 1378 @ $1.041 vs 50109 OI; Ref=$9.795,2019-11-13 13:30:00-05:00,TEVA,positive
1221837.0,"Teva Vs. Amneal: JPMorgan Sees Hope For One, Decline For The Other",2019-11-12 10:47:00-05:00,TEVA,positive
1221838.0,Teva Shares Unaffected Following Earlier Bloomberg Article 'Teva's Links to Opioid Epidemic May Triple Funding Costs',2019-11-12 10:29:00-05:00,TEVA,positive
1221839.0,"UPDATE: JP Morgan On Teva Also Notes 'However, TEVA's near-to-mid-term fundamentals are stabilizing (unlike some of its peers). Further, mgmt's comments on opioids appear encouraging'",2019-11-12 09:33:00-05:00,TEVA,positive
1221840.0,"UPDATE: JP Morgan Upgrades Teva To Neutral, Notes 'We remain fairly bearish on the longer-term setup for the company between its lack of growth-drivers (Ajovy underperforming expectations so far, lingering LOEs, etc.) and still high-leverage'",2019-11-12 09:32:00-05:00,TEVA,positive
1221841.0,JP Morgan Upgrades Teva Pharmaceutical Indus to Neutral,2019-11-12 06:36:00-05:00,TEVA,positive
1221842.0,5 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-11-11 07:42:00-05:00,TEVA,neutral
1221843.0,20 Stocks Moving in Monday's Pre-Market Session,2019-11-11 07:40:00-05:00,TEVA,neutral
1221844.0,Teva Pharmaceuticals shares are trading higher depsite announcing a $1.5 billion senior notes offering.,2019-11-08 11:11:00-05:00,TEVA,positive
1221845.0,Teva Announces LAunch Of $1.5B Senior Notes Offering,2019-11-08 09:44:00-05:00,TEVA,neutral
1221846.0,"PiperJaffray Maintains Neutral on Teva Pharmaceutical Indus, Raises Price Target to $7",2019-11-08 09:40:00-05:00,TEVA,neutral
1221847.0,10 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-08 07:48:00-05:00,TEVA,neutral
1221848.0,Teva Pharmaceuticals shares are trading higher after the company reported better-than-expected Q3 sales results. The company also issued FY19 sales guidance above analyst estimates.,2019-11-07 09:06:00-05:00,TEVA,positive
1221849.0,Teva Announces Appointment of Eli Kalif As Executive Vice President And New Chief Financial Officer,2019-11-07 07:36:00-05:00,TEVA,neutral
1221850.0,"Teva and Celltrion Announce The Availability Of TRUXIMA Injection, The First Biosimilar To The Reference Product Rituxan in the United States With Full Oncology Label",2019-11-07 07:22:00-05:00,TEVA,positive
1221851.0,"Teva Narrows FY19 Guidance: Sales From $17B-$17.4B To $17.2B-$17.4B vs $17.18B Estimate, EPS From $2.20-$2.50 To $2.30-$2.50 vs $2.38 Est.",2019-11-07 07:04:00-05:00,TEVA,neutral
1221852.0,"Teva Pharmaceutical Indus Q3 Adj. EPS $0.58, Inline, Sales $4.264B Beat $4.22B Estimate",2019-11-07 07:03:00-05:00,TEVA,neutral
1221853.0,"Earnings Scheduled For November 7, 2019",2019-11-07 04:22:00-05:00,TEVA,neutral
1221854.0,17 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-11-06 07:52:00-05:00,TEVA,neutral
1221855.0,"Teva Pharmaceuticals shares are trading higher in sympathy with the overall market on positive U.S.-China trade news. The National Security Adviser Robert O'Brien said: ""we're relatively close to an agreement.""",2019-11-04 11:53:00-05:00,TEVA,positive
1221856.0,Teva Shares Fall Slightly From Session High; Traders Circulate Word Debtwire Suggesting Co. Could Be 1 Of Opioid Manufacturers To Chapter 11,2019-10-24 14:53:00-04:00,TEVA,positive
1221857.0,Teva Pharmaceutical Indus Option Alert: Dec 20 $8 Puts Sweep (11) near the Ask: 600 @ $1.0 vs 48730 OI; Earnings 11/7 Before Open Ref=$7.71,2019-10-23 11:38:00-04:00,TEVA,positive
1221858.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tuesday, October 22, 2019",2019-10-22 10:20:00-04:00,TEVA,positive
1221859.0,"PreMarket Prep: Schizophrenic Drug Stocks, A Technical Play On Halliburton's Q3 Report",2019-10-21 15:08:00-04:00,TEVA,positive
1221860.0,"'co-lead attorneys for the plaintiff municipalities tell me they are not on board with $TEVA framework for agreement in principle. ""This appears to be the same proposal that 17 municipalities rejected...' -CNBC's Meg Tirrell",2019-10-21 14:53:00-04:00,TEVA,positive
1221861.0,"Attorney For Local Gov't. Says Opioid Global Settlement Talks With Teva, Distributors Could Resume As Early As Tues.",2019-10-21 14:50:00-04:00,TEVA,neutral
1221862.0,Mallinckrodt Shares Spike ~6% On Heavy Volume As Teva Confirms Settlement In Track 1 Opioid Case,2019-10-21 13:57:00-04:00,TEVA,positive
1221863.0,Teva Pharmaceutical shares are trading higher after the company reached a settlement with Cuyahoga and Summit counties regarding its opioid litigation.,2019-10-21 13:55:00-04:00,TEVA,positive
1221864.0,Endo Shares Spike 3% On Uptick In Volume Following Confirmation From Teva Of A Settlement In Track 1 Opioid Case,2019-10-21 13:55:00-04:00,TEVA,positive
1221865.0,"UPDATE: Teva To Provide 2 Counties With Critical Opioid Treatment Medication Distributed Over 3 Years, Make $20M Cash Payment Over 3 Years",2019-10-21 13:54:00-04:00,TEVA,negative
1221866.0,Teva Reports Details Of Track 1 Opioid Cases Settlement,2019-10-21 13:53:00-04:00,TEVA,neutral
1221867.0,"Plaintiff Attorney In Opioid Case Says McKesson, AmerisourceBergen, Cardinal Health Have Settled 2 Cases In Ohio For $215M, Teva To Settle For $20M In Cash Plus $25M In Donated Addiction-Treatment Drugs, Walgreens Trial Postponed",2019-10-21 09:23:00-04:00,TEVA,negative
1221868.0,"4 Pharma Companies Settle Opioid Lawsuits Ahead Of Trial With Ohio Counties; 2,300 Cases Remain",2019-10-21 09:08:00-04:00,TEVA,negative
1221869.0,Shares of opioid-related drug companies are trading lower after the WSJ reported that a settlement has been reached in the opioid addiction lawsuit. The settlement is expected to be announced today.,2019-10-21 08:55:00-04:00,TEVA,negative
1221870.0,"Foamix Announces Settlement of Litigation with Teva Relating to Finacea Foam, Terms Not Disclosed",2019-10-21 08:11:00-04:00,TEVA,negative
1221871.0,"McKesson, Cardinal Health, AmerisourceBergen and Teva Opioid Settlement Details Will be Announced Today, According to the Wall Street Journal",2019-10-21 07:54:00-04:00,TEVA,neutral
1221872.0,11 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-10-21 07:46:00-04:00,TEVA,neutral
1221873.0,26 Stocks Moving in Monday's Pre-Market Session,2019-10-21 07:41:00-04:00,TEVA,neutral
1221874.0,"Barron's Picks And Pans: Boeing, Comcast, Conoco, Emerson And More",2019-10-20 08:13:00-04:00,TEVA,neutral
1221875.0,48 Biggest Movers From Yesterday,2019-10-18 06:55:00-04:00,TEVA,neutral
1221876.0,Teva Pharmaceutical Indus Option Alert: Dec 20 $6 Puts Sweep (26) near the Ask: 1239 @ $0.399 vs 51665 OI; Earnings 11/7 Before Open Ref=$7.44,2019-10-17 12:50:00-04:00,TEVA,positive
1221877.0,"UK's MHRA Issued Alert To Healthcare Professionals, As Teva UK Is Recalling All Unexpired Stock Of Certain Batches Of 2 Types Of Ranitidine",2019-10-17 09:31:00-04:00,TEVA,positive
1221878.0,Teva Pharmaceutical Industries shares are trading higher after Gabelli & Co upgraded the stock from Hold to Buy.,2019-10-17 08:45:00-04:00,TEVA,positive
1221879.0,14 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-10-17 07:42:00-04:00,TEVA,neutral
1221880.0,Gabelli & Co. Upgrades Teva Pharmaceutical Indus to Buy,2019-10-17 06:52:00-04:00,TEVA,neutral
1221881.0,Opioid Drug Companies Rally On Hopes of Broader Settlement,2019-10-16 11:56:00-04:00,TEVA,positive
1221882.0,17 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-16 07:57:00-04:00,TEVA,neutral
1221883.0,23 Stocks Moving in Wednesday's Pre-Market Session,2019-10-16 07:40:00-04:00,TEVA,neutral
1221884.0,"Jim Cramer Shares His Thoughts On Teva Pharmaceutical, MGM Resorts And More",2019-10-12 18:08:00-04:00,TEVA,positive
1221885.0,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,2019-10-11 11:19:00-04:00,TEVA,positive
1221886.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-09 07:54:00-04:00,TEVA,neutral
1221887.0,Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15.,2019-10-08 10:36:00-04:00,TEVA,positive
1221888.0,Sell-Side Positive On Johnson & Johnson's Unexpected Ohio Opioid Settlement,2019-10-02 15:06:00-04:00,TEVA,positive
1221889.0,Teva Pharmaceutical Indus Option Alert: Nov 15 $8 Calls Sweep (9) near the midpoint: 706 @ $0.331 vs 829 OI; Earnings 10/31 Before Open [est] Ref=$6.8966,2019-10-02 10:10:00-04:00,TEVA,positive
1221890.0,23 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-01 08:24:00-04:00,TEVA,neutral
1221891.0,"Wells Fargo Maintains Market Perform on Teva Pharmaceutical Indus, Lowers Price Target to $8",2019-09-30 07:55:00-04:00,TEVA,positive
1221892.0,Teva Pharmaceuticals shares are trading higher on a potential rebound after the stock dropped approximately 10% in the last 4 days.,2019-09-27 11:00:00-04:00,TEVA,positive
1221893.0,Teva Pharmaceutical Industries shares are trading lower despite no company-specific news. The stock has dropped approximately 13% in the last 5 days.,2019-09-26 11:48:00-04:00,TEVA,positive
1221894.0,"Shares of several cannabis companies are trading lower, led by Canopy Growth which is down 7% amid news indicating GTEC will no longer purchase a Canopy Growth facility. This could also be a sympathy play with tobacco companies amid fears related to regulatory concerns about vaping/flavored e-cigs.",2019-09-19 15:19:00-04:00,TEVA,positive
1221895.0,9 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-09-17 08:13:00-04:00,TEVA,neutral
1221896.0,Purdue Pharma Files For Bankruptcy: What You Need To Know,2019-09-16 10:58:00-04:00,TEVA,neutral
1221897.0,"The Week In Cannabis: Big Pharma Makes Moves, Diddy & Wahlberg Go After CBD, Medicine Man Continues M&A Spree",2019-09-13 16:54:00-04:00,TEVA,neutral
1221898.0,Teva Dips Into Medical Marijuana Market With Canndoc Distribution Deal,2019-09-13 08:14:00-04:00,TEVA,neutral
1221899.0,InterCure Subsidiary Canndoc Signs Strategic Distribution Agreement with S.L.E. of TEVA Pharmaceuticals,2019-09-13 06:12:00-04:00,TEVA,positive
1221900.0,Guggenheim Initiates Coverage On Teva Pharmaceutical Indus with Neutral Rating,2019-09-12 07:17:00-04:00,TEVA,neutral
1221901.0,"Teva Canada Reports Approval Of Herzuma For Treatment Of Adult Patients With Early Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer",2019-09-11 10:15:00-04:00,TEVA,negative
1221902.0,Teva Pharmaceutical shares are trading higher on seemingly no news.,2019-09-10 13:39:00-04:00,TEVA,neutral
1221903.0,Pelosi's Drug Pricing Plan is More Aggressive than Expected,2019-09-09 20:23:00-04:00,TEVA,negative
1221904.0,"JP Morgan Maintains Underweight on Teva Pharmaceutical Indus, Lowers Price Target to $7",2019-09-06 12:31:00-04:00,TEVA,positive
1221905.0,55 Stocks Moving In Thursday's Mid-Day Session,2019-09-05 12:27:00-04:00,TEVA,neutral
1221906.0,Mallinckrodt Eyes Restructuring Ahead Of Cleveland Opioid Trial: 'Bankruptcy A Real Option',2019-09-05 10:39:00-04:00,TEVA,neutral
1221907.0,9 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-09-05 08:15:00-04:00,TEVA,neutral
1221908.0,26 Stocks Moving in Thursday's Pre-Market Session,2019-09-05 07:44:00-04:00,TEVA,neutral
1221909.0,"Teva Highlights Will Present New Analyses Of Fremanezumab Efficacy, Safety In Adult Patients With Difficult-To-Treat Migraine At Congress of the International Headache Society",2019-09-04 16:24:00-04:00,TEVA,positive
1221910.0,"Teva Highlights Presentation Of New Analyses Of Fremanezumab Efficacy, Safety In Adults With Difficult-To-Treat Migraine At Congress Of Int'l. Headache Society",2019-09-03 09:06:00-04:00,TEVA,positive
1221911.0,23 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-08-29 08:40:00-04:00,TEVA,neutral
1221912.0,64 Biggest Movers From Yesterday,2019-08-28 05:10:00-04:00,TEVA,neutral
1221913.0,46 Stocks Moving In Tuesday's Mid-Day Session,2019-08-27 14:47:00-04:00,TEVA,neutral
1221914.0,Why One Johnson & Johnson Analyst Sees Oklahoma Opioid Ruling As Near-Term Sentiment Positive,2019-08-27 13:03:00-04:00,TEVA,positive
1221915.0,"Shares of several healthcare companies are trading lower after an Oklahoma Judge ruled against Johnson & Johnson in its opioid case. The case is viewed as potential precedent for 2,000 other pending suits expected to be heard in Ohio in October.",2019-08-27 12:02:00-04:00,TEVA,neutral
1221916.0,12 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-08-27 08:24:00-04:00,TEVA,neutral
1221917.0,26 Stocks Moving in Tuesday's Pre-Market Session,2019-08-27 08:05:00-04:00,TEVA,neutral
1221918.0,"Teva Pharmaceutical Indus Option Alert: Jan, 2021 $10 Calls at the Ask: 1000 @ $1.761 vs 20659 OI; Ref=$7.5",2019-08-26 14:16:00-04:00,TEVA,positive
1221919.0,"Teva shares are trading higher, potentially in anticipation of an Oklahoma court's expected 4pm decision in an opioid case against Johnson & Johnson. While Teva previously settled an opioid case in Oklahoma, the J&J verdict could impact the sector.",2019-08-26 13:58:00-04:00,TEVA,positive
1221920.0,"Jim Cramer Weighs In On Pfizer, Teva And More",2019-08-22 11:08:00-04:00,TEVA,neutral
1221921.0,12 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-08-22 08:47:00-04:00,TEVA,neutral
1221922.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-08-21 08:48:00-04:00,TEVA,neutral
1221923.0,55 Biggest Movers From Yesterday,2019-08-21 05:07:00-04:00,TEVA,neutral
1221924.0,44 Stocks Moving In Tuesday's Mid-Day Session,2019-08-20 12:21:00-04:00,TEVA,neutral
1221925.0,TEVA shares are trading higher after the company announced a generic EpiPen Jr in the U.S.,2019-08-20 09:42:00-04:00,TEVA,positive
1221926.0,"Teva Announces Availability Of A Generic Equivalent Of EpiPen Jr Auto-Injector, 0.15 mg In The United States",2019-08-20 08:08:00-04:00,TEVA,positive
1221927.0,Shares of several healthcare companies are trading higher as optimism increased for a resolution to the US-China trade war.,2019-08-19 12:31:00-04:00,TEVA,positive
1221928.0,"Shares of healthcare companies are trading higher as US markets rebound from recent weakness following a yield curve inversion, which caused recession fears. Trump also recently announced the US would delay China tariffs, renewing hopes of a trade deal.",2019-08-16 13:27:00-04:00,TEVA,negative
1221929.0,"The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission",2019-08-16 07:33:00-04:00,TEVA,negative
1221930.0,"The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings",2019-08-15 07:45:00-04:00,TEVA,neutral
1221931.0,32 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-08-14 08:50:00-04:00,TEVA,neutral
1221932.0,"House Oversight Panel Chairman Renews Request for Documents From Mylan, Teva Pharmaceutical and Heritage Pharmaceuticals on Generic Drug Price Increases[ Says Panel is Probing Mylan, Teva and Heritage's Apparent Coordinated Obstruction of Drug Pricing Investigation",2019-08-14 06:31:00-04:00,TEVA,neutral
1221933.0,﻿Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,2019-08-13 11:53:00-04:00,TEVA,positive
1221934.0,25 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-08 08:35:00-04:00,TEVA,neutral
1221935.0,52 Stocks Moving In Thursday's Pre-Market Session,2019-08-08 07:49:00-04:00,TEVA,neutral
1221936.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,TEVA,negative
1221937.0,Teva shares trading lower despite reporting a Q2 earnings and sales beat.,2019-08-07 10:04:00-04:00,TEVA,neutral
1221938.0,From Teva Q2 Earnings Conference Call: CEO Says Will Stay With Co. For At Least Through 5-Year Contract,2019-08-07 08:48:00-04:00,TEVA,neutral
1221939.0,From Teva Q2 Earnings Conference Call: Sees Likely Some Opioid Cases In States Could Be Settled,2019-08-07 08:39:00-04:00,TEVA,neutral
1221940.0,"Teva Reports Q2 Earnings Beat, Reaffirms Guidance",2019-08-07 07:52:00-04:00,TEVA,neutral
1221941.0,Teva Pharma Reports CFO Mike McClellan To Step Down; Co. Initiated Search For Replacement,2019-08-07 07:49:00-04:00,TEVA,neutral
1221942.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,TEVA,neutral
1221943.0,"Teva Pharmaceutical Indus Q2 Adj. EPS $0.6 Beats $0.57 Estimate, Sales $4.337B Beat $4.25B Estimate",2019-08-07 07:07:00-04:00,TEVA,neutral
1221944.0,"10 Stocks To Watch For August 7, 2019",2019-08-07 05:20:00-04:00,TEVA,neutral
1221945.0,"Earnings Scheduled For August 7, 2019",2019-08-07 04:43:00-04:00,TEVA,neutral
1221946.0,Teva Pharmaceutical Q2 Earnings Preview,2019-08-06 14:55:00-04:00,TEVA,neutral
1221947.0,Shares of several oil and gas companies are trading lower amid renewed U.S.-China trade tensions. NOTE: Oil companies do not appear to be rebounding along with the overall market.,2019-08-06 11:36:00-04:00,TEVA,negative
1221948.0,Teva Pharmaceutical Indus Option Alert: Oct 18 $10 Calls Sweep (11) near the Ask: 936 @ $0.29 vs 1566 OI; Earnings 8/7 Before Open Ref=$7.85,2019-08-01 15:17:00-04:00,TEVA,positive
1221949.0,Bausch Health Agree To Resolve Intellectual Property Litigation With Teva,2019-07-31 16:26:00-04:00,TEVA,positive
1221950.0,Teva Pharmaceutical Indus Option Alert: Sep 20 $9 Calls at the Ask: 500 @ $0.451 vs 13264 OI; Earnings 8/7 Before Open Ref=$7.9969,2019-07-31 11:34:00-04:00,TEVA,positive
1221951.0,Teva Pharmaceutical Indus Option Alert: Sep 20 $9 Calls Sweep (15) near the Ask: 500 @ $0.42 vs 13264 OI; Earnings 8/7 Before Open Ref=$7.9299,2019-07-31 11:26:00-04:00,TEVA,positive
1221952.0,"A Look At Benzinga Pro's Most-Searched Tickers For July 29, 2019",2019-07-29 11:35:00-04:00,TEVA,neutral
1221953.0,Teva Pharmaceutical Indus Option Alert: Oct 18 $9 Calls Sweep (10) near the Ask: 517 @ $0.47 vs 1989 OI; Earnings 8/7 Before Open Ref=$7.76,2019-07-29 10:35:00-04:00,TEVA,positive
1221954.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Mon., July 29, 2019",2019-07-29 09:54:00-04:00,TEVA,positive
1221955.0,30 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-29 09:35:00-04:00,TEVA,neutral
1221956.0,35 Stocks Moving In Monday's Pre-Market Session,2019-07-29 08:30:00-04:00,TEVA,neutral
1221957.0,Teva Pharmaceutical shares are trading higher following a merger between generic drug maker Mylan and Pfizer's off-patent Upjohn division.,2019-07-29 08:22:00-04:00,TEVA,positive
1221958.0,Large Option Trader Makes Aggressive Bearish Play On Teva,2019-07-22 13:36:00-04:00,TEVA,positive
1221959.0,8 Of The Best Investments For Boomers Concerned About Retirement,2019-07-22 10:30:00-04:00,TEVA,positive
1221960.0,Teva Shares Unaffected As Traders Circulate 'Teva's Sinking Bond Price Poses Insolvency Threat' -Haaretz,2019-07-18 10:46:00-04:00,TEVA,negative
1221961.0,Option Trader Makes Bullish Bet On Lannett Rebound,2019-07-16 13:42:00-04:00,TEVA,neutral
1221962.0,52 Biggest Movers From Yesterday,2019-07-16 05:15:00-04:00,TEVA,neutral
1221963.0,42 Stocks Moving In Monday's Mid-Day Session,2019-07-15 12:47:00-04:00,TEVA,neutral
1221964.0,"Morgan Stanley Downgrades Teva, Endo On Drug Pricing And Litigation Concerns",2019-07-15 10:35:00-04:00,TEVA,negative
1221965.0,10 Biggest Price Target Changes For Monday,2019-07-15 09:48:00-04:00,TEVA,neutral
1221966.0,"Benzinga's Top Upgrades, Downgrades For July 15, 2019",2019-07-15 09:38:00-04:00,TEVA,positive
1221967.0,Teva Announces FDA Approval Of AirDuo Digihaler,2019-07-15 08:30:00-04:00,TEVA,positive
1221968.0,30 Stocks Moving In Monday's Pre-Market Session,2019-07-15 08:07:00-04:00,TEVA,neutral
1221969.0,Teva Pharmaceutical shares are trading lower after Morgan Stanley downgraded the company's stock from Equal-Weight to Underweight and lowered the price target from $16 to $6.,2019-07-15 07:43:00-04:00,TEVA,negative
1221970.0,"Morgan Stanley Downgrades Teva Pharmaceutical Indus to Underweight, Lowers Price Target to $6",2019-07-15 07:02:00-04:00,TEVA,negative
1221971.0,Teva Shares Fall 5.7% Premarket Following Downgrade at Morgan Stanley to Underweight from Equal Weight,2019-07-15 06:11:00-04:00,TEVA,positive
1221972.0,Shares of several healthcare companies in the pharmaceutical space are trading lower after Amneal Pharmaceuticals announced a cost reduction plan in response to the continuing industry challenges. Amneal cut guidance as part of plan.,2019-07-10 11:37:00-04:00,TEVA,negative
1221973.0,"Cantor Fitzgerald Comments On The Weakness In Healthcare Companies, Notes 'AMRX undertook the additional cost reduction in response to the continuing industry challenges.'; Says This Has Had Readthrough To Other Generics Names",2019-07-10 11:26:00-04:00,TEVA,negative
1221974.0,Credit Suisse Assumes Teva Pharmaceutical Indus at Neutral,2019-07-10 09:26:00-04:00,TEVA,positive
1221975.0,"Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs.",2019-07-08 12:55:00-04:00,TEVA,positive
1221976.0,"Bulls And Bears Of The Week: Apple, Nike, Tesla, Uber And More",2019-07-06 15:04:00-04:00,TEVA,neutral
1221977.0,Teva's Migraine Prevention Drug Meets Exploratory Endpoints,2019-07-02 10:29:00-04:00,TEVA,neutral
1221978.0,"The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug",2019-07-02 07:29:00-04:00,TEVA,positive
1221979.0,Teva Presents Positive Results Showing Improvement in Disability and Quality of Life from the Phase IIIb FOCUS study of Fremanezumab in Adults with Migraine at #EAN2019,2019-07-02 04:15:00-04:00,TEVA,positive
1221980.0,Teva Announces Launch of 1% Sodium Hyaluronate in the United States,2019-07-01 08:35:00-04:00,TEVA,positive
1221981.0,Teva Shares Tick Lower On Spike In Volume; Hearing CBS Show 'Whistleblowers' Will Feature An Undercover Pharma Salesperson,2019-06-28 12:49:00-04:00,TEVA,neutral
1221982.0,28 Stocks Moving In Friday's Pre-Market Session,2019-06-28 08:13:00-04:00,TEVA,neutral
1221983.0,Shares of multiple drugmakers and biotech companies are trading higher after AbbVie announced it will acquire Allergan.,2019-06-25 11:21:00-04:00,TEVA,positive
1221984.0,Oklahoma Judge Approves Teva Pharmaceutical Industries Ltd'S $85 Million Opioid Lawsuit Settlement,2019-06-24 14:41:00-04:00,TEVA,positive
1221985.0,Teva Pharmaceutical Indus Option Alert: Fri $8 Calls Sweep (14) near the Ask: 506 @ $0.411 vs 1503 OI; Earnings 8/1 Before Open [est] Ref=$8.315,2019-06-24 14:40:00-04:00,TEVA,positive
1221986.0,Teva Pharmaceutical Indus Option Alert: Fri $8 Calls Sweep (14) near the Ask: 506 @ $0.411 vs 1503 OI; Earnings 8/1 Before Open [est] Ref=$8.315,2019-06-24 14:40:00-04:00,TEVA,positive
1221987.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Thur., June 20, 2019",2019-06-20 14:25:00-04:00,TEVA,positive
1221988.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Wed., June 19, 2019",2019-06-19 13:06:00-04:00,TEVA,positive
1221989.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Tue., June 18, 2019",2019-06-18 13:19:00-04:00,TEVA,positive
1221990.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Mon., June 17, 2019",2019-06-17 13:43:00-04:00,TEVA,positive
1221991.0,"Teva Pharmaceuticals USA Expands Voluntary Nationwide Recall Of Losartan Potassium To 50 Mg And 100 Mg Tablets Usp, Sold Exclusively To Golden State Medical Supply",2019-06-11 13:10:00-04:00,TEVA,positive
1221992.0,"Barclays Initiates Coverage On Teva Pharmaceutical Indus with Underweight Rating, Announces $8 Price Target",2019-06-11 07:16:00-04:00,TEVA,neutral
1221993.0,"Notable Insider Buys This Past Week: American Airlines, MGM and More",2019-06-09 16:28:00-04:00,TEVA,neutral
1221994.0,"The Daily Biotech Pulse: Curtains Down On ASCO, Rewalk Flies, Eli Lilly's Migraine Drug Approved For Cluster Headache",2019-06-05 07:30:00-04:00,TEVA,positive
1221995.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,TEVA,positive
1221996.0,51 Stocks Moving In Monday's Mid-Day Session,2019-06-03 12:46:00-04:00,TEVA,neutral
1221997.0,Teva Pharmaceutical shares are trading higher after Oppenheimer upgraded the company's stock from Perform to Outperform. The upgrade comes amid ongoing concerns over the company's recently-settled opioid lawsuit in Oklahoma.,2019-06-03 09:40:00-04:00,TEVA,positive
1221998.0,"Benzinga's Top Upgrades, Downgrades For June 3, 2019",2019-06-03 09:18:00-04:00,TEVA,positive
1221999.0,30 Stocks Moving In Monday's Pre-Market Session,2019-06-03 08:12:00-04:00,TEVA,neutral
1222000.0,"Oppenheimer Upgrades Teva Pharmaceutical Indus to Outperform, Announces $12 Price Target",2019-06-03 08:01:00-04:00,TEVA,neutral
1222001.0,"Bulls & Bears Of The Week: Apple, Nio, Snap, Uber And More",2019-06-02 15:50:00-04:00,TEVA,neutral
1222002.0,"The Daily Biotech Pulse: Merrimack To Stay Independent, Chinese Cheer For Beigene, XBiotech Offering",2019-05-31 07:34:00-04:00,TEVA,positive
1222003.0,Johnson & Johnson Analyst: 3 Takeaways On Opioid Litigation,2019-05-30 13:56:00-04:00,TEVA,negative
1222004.0,Teva  shares are trading lower after Bank of America downgraded the stock from Buy to Underperform and lowered the price target from $19 to $9. The company has seen weakness since its recent opioid settlement with Oklahoma.,2019-05-30 13:26:00-04:00,TEVA,negative
1222005.0,"UPDATE: Bank Of America Downgrades Teva From Buy To Underperform, Lowers Target From $19 To $9 As Firm Notes Co's 'exposure to various ongoing opioid litigation' And A 'Lack of needle-moving catalysts'",2019-05-30 12:02:00-04:00,TEVA,negative
1222006.0,10 Biggest Price Target Changes For Thursday,2019-05-30 09:51:00-04:00,TEVA,neutral
1222007.0,"Benzinga's Top Upgrades, Downgrades For May 30, 2019",2019-05-30 08:55:00-04:00,TEVA,positive
1222008.0,"The Daily Biotech Pulse: Unity Biotech Licenses Anti-Aging Protein, Strong Results For Mereo's Brittle Bone Disease Drug",2019-05-30 07:33:00-04:00,TEVA,positive
1222009.0,"Bank of America Downgrades Teva Pharmaceutical Indus to Underperform, Lowers Price Target to $9 Price Target",2019-05-30 07:10:00-04:00,TEVA,negative
1222010.0,"Teva's Legal Overhang Triggers UBS Downgrade, Near-Halving Of Price Target",2019-05-29 14:23:00-04:00,TEVA,positive
1222011.0,"The Daily Biotech Pulse: Inovio's Partner Scales Back R&D Collaboration, Genmab Seeks Nasdaq Listing, Bayer Gets Breakthrough Therapy Designation",2019-05-29 07:38:00-04:00,TEVA,neutral
1222012.0,65 Biggest Movers From Yesterday,2019-05-29 05:10:00-04:00,TEVA,neutral
1222013.0,Mid-Afternoon Market Update: Dow Falls 50 Points; Soliton Shares Gain On FDA Approval For Tattoo Removal Device,2019-05-28 14:34:00-04:00,TEVA,positive
1222014.0,Teva Announces Launch Of A Generic Version Of Ranexa (Ranolazine) Extended-Release Tablets In The United States,2019-05-28 12:48:00-04:00,TEVA,positive
1222015.0,44 Stocks Moving In Tuesday's Mid-Day Session,2019-05-28 12:27:00-04:00,TEVA,neutral
1222016.0,Teva Pharmaceutical shares are trading lower after UBS downgraded the stock from from Buy to Neutral. The company also recently settled its opioid case in Oklahoma for $85M.,2019-05-28 09:56:00-04:00,TEVA,neutral
1222017.0,10 Biggest Price Target Changes For Tuesday,2019-05-28 09:52:00-04:00,TEVA,neutral
1222018.0,"Benzinga's Top Upgrades, Downgrades For May 28, 2019",2019-05-28 09:15:00-04:00,TEVA,positive
1222019.0,"UBS Downgrades Teva Pharmaceutical Indus to Neutral, Lowers Price Target to $12 Price Target",2019-05-28 07:10:00-04:00,TEVA,negative
1222020.0,"The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice",2019-05-24 07:44:00-04:00,TEVA,neutral
1222021.0,Shares of several companies in the healthcare sector are trading lower. Not seeing any news to justify this price action.,2019-05-22 15:07:00-04:00,TEVA,neutral
1222022.0,"Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",2019-05-17 09:21:00-04:00,TEVA,neutral
1222023.0,"The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics",2019-05-16 07:40:00-04:00,TEVA,neutral
1222024.0,60 Biggest Movers From Yesterday,2019-05-16 05:12:00-04:00,TEVA,neutral
1222025.0,44 Stocks Moving In Wednesday's Mid-Day Session,2019-05-15 12:56:00-04:00,TEVA,neutral
1222026.0,"13F For JANA Shows Liquidated Stakes In Apple, Adobe, Anthem, Autodesk, Boston Scientific, Mastercard, Microsoft, Teva, Tiffany",2019-05-15 09:37:00-04:00,TEVA,neutral
1222027.0,Teva Pharmaceuticals Industries shares are continuing lower after the United States filed a lawsuit against the company alleging price fixing in 44 states on Monday.,2019-05-15 09:13:00-04:00,TEVA,positive
1222028.0,26 Stocks Moving In Wednesday's Pre-Market Session,2019-05-15 08:21:00-04:00,TEVA,neutral
1222029.0,Options Traders Making Big Long-Term Bets On Teva,2019-05-14 12:50:00-04:00,TEVA,neutral
1222030.0,Teva Pharmaceutical Indus Option Alert: Jan 17 $12.5 Calls Sweep (2) above Ask!: 1521 @ $1.896 vs 2203 OI; Ref=$12.36,2019-05-14 09:42:00-04:00,TEVA,positive
1222031.0,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",2019-05-14 07:42:00-04:00,TEVA,positive
1222032.0,50 Biggest Movers From Yesterday,2019-05-14 05:39:00-04:00,TEVA,neutral
1222033.0,42 Stocks Moving In Monday's Mid-Day Session,2019-05-13 12:48:00-04:00,TEVA,neutral
1222034.0,"Benzinga Pro's Top 8 Most-Searched Tickers For Morning of Mon., May 13, 2019",2019-05-13 10:24:00-04:00,TEVA,positive
1222035.0,Teva Plummets Amid Massive Price Fixing Accusations; Other Generic Drugmakers Also Fall,2019-05-13 08:40:00-04:00,TEVA,negative
1222036.0,30 Stocks Moving In Monday's Pre-Market Session,2019-05-13 08:15:00-04:00,TEVA,neutral
1222037.0,Teva shares are trading lower after the United States filed a lawsuit against the company alleging price fixing.,2019-05-13 07:45:00-04:00,TEVA,positive
1222038.0,Teva Reports Launch Of Generic Version Of Delzicol Delayed-Release Capsules In US,2019-05-10 11:52:00-04:00,TEVA,neutral
1222039.0,"The Daily Biotech Pulse: FibroGen Kidney Disease Trial Disappoints, Medtronic To Buy Titan Spine, Puma's Weak Breast Cancer Drug Sales",2019-05-10 08:00:00-04:00,TEVA,negative
1222040.0,Teva Announces Launch Of Generic Version Of Tarceva Tablets In US,2019-05-09 16:58:00-04:00,TEVA,neutral
1222041.0,Shares of several multinational companies are trading lower following a tweet from President Trump which hinted at additional tariffs on China and China indicated it may back out of upcoming trade negotiations.,2019-05-06 09:17:00-04:00,TEVA,neutral
1222042.0,"Teva Will Present New Long-Term Data On Efficacy, Safety Of Fremanezumab At American Academy of Neurology Annual Meeting",2019-05-03 08:06:00-04:00,TEVA,positive
1222043.0,Teva Pharmaceutical Industries shares are trading lower after the company reported worse-than-expected Q1 sales.,2019-05-02 08:56:00-04:00,TEVA,neutral
1222044.0,"Teva Reaffirms FY19 Sales, EPS Guidance",2019-05-02 07:06:00-04:00,TEVA,neutral
1222045.0,"Teva Pharmaceutical Indus Q1 EPS $0.6 Beats $0.58 Estimate, Sales $4.295B Miss $4.38B Estimate",2019-05-02 07:06:00-04:00,TEVA,negative
1222046.0,"Earnings Scheduled For May 2, 2019",2019-05-02 04:43:00-04:00,TEVA,neutral
1222047.0,Teva Announces Launch Of Generic Version Of Letairis Tablets In US,2019-05-01 15:05:00-04:00,TEVA,neutral
1222048.0,"The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug",2019-04-26 08:02:00-04:00,TEVA,negative
1222049.0,"Teva Issues Voluntary Nationwide Recall Of Losartan Ptassium 25 Mg, 100 Mg Tablets USP",2019-04-25 17:16:00-04:00,TEVA,neutral
1222050.0,"Shares of several healthcare-related stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'.",2019-04-23 14:30:00-04:00,TEVA,positive
1222051.0,Teva Pharma To Discontinue Clinical Development Program For Use Of Fremanezumab In Cluster Headaches,2019-04-23 09:01:00-04:00,TEVA,neutral
1222052.0,"Teva Pharmaceutical Industries Announces The Launch Of A Generic Version Of Vesicare 1 (Solifenacin Succinate) Tablets, 5 Mg And 10 Mg, In The U.S",2019-04-22 11:05:00-04:00,TEVA,neutral
1222053.0,"The Daily Biotech Pulse: Hookipa To Debut, Mustang Bio Skyrockets, AngioDynamics Sheds Portfolio",2019-04-18 07:42:00-04:00,TEVA,neutral
1222054.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-17 10:31:00-04:00,TEVA,negative
1222055.0,Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville,2019-04-16 07:05:00-04:00,TEVA,positive
1222056.0,Eagle Pharma Increases its Royalty Payment Split with Teva Pharma,2019-04-15 06:53:00-04:00,TEVA,neutral
1222057.0,"The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug",2019-04-12 07:47:00-04:00,TEVA,positive
1222058.0,Teva Highlights Launch Of Generic Version Of AndroGel In US,2019-04-11 10:00:00-04:00,TEVA,neutral
1222059.0,"Citigroup Maintains Buy on Teva Pharmaceutical Indus, Lowers Price Target to $23",2019-04-11 09:31:00-04:00,TEVA,negative
1222060.0,"The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug",2019-04-11 07:48:00-04:00,TEVA,positive
1222061.0,Teva Pharmaceutical Indus Option Alert: Sep 20 $14 Calls Sweep (2) near the Ask: 500 @ $1.95 vs 145 OI; Earnings 5/2 Before Open [est] Ref=$14.4,2019-04-10 10:20:00-04:00,TEVA,positive
1222062.0,"Teva Reports Its Teva Canada Subsidiary Received Approval Of TRUXIMA In Canada For Treatment of Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia and Rheumatoid Arthritis",2019-04-10 08:07:00-04:00,TEVA,positive
1222063.0,Teva Reports Signing Of New $2.3B Syndicated Revolving Credit Facility,2019-04-10 08:00:00-04:00,TEVA,positive
1222064.0,"The Daily Biotech Pulse: Amgen's Bone-Building Osteoporosis Drug Clears FDA Muster, PhaseBio Offering",2019-04-10 07:32:00-04:00,TEVA,positive
1222065.0,"Wells Fargo Maintains Market Perform on Teva Pharmaceutical Indus, Lowers Price Target to $18",2019-04-03 09:53:00-04:00,TEVA,positive
1222066.0,Univo To Develop Cannabis Inhaler Formulation For Sanara Ventures' Veoli,2019-04-02 17:29:00-04:00,TEVA,neutral
1222067.0,Teva's AJOVY Receives EU Approval Offering Patients The First And Only Anti-CGRP Treatment With Both Quarterly And Monthly Dosing For The Prophylaxis Of Migraine In Adults,2019-04-01 08:09:00-04:00,TEVA,positive
1222068.0,Teva Announces Favorable Response from European Patent Office Upholding COPAXONE 40mg Patent,2019-04-01 04:10:00-04:00,TEVA,positive
1222069.0,"Benzinga's Top Upgrades, Downgrades For March 28, 2019",2019-03-28 09:18:00-04:00,TEVA,positive
1222070.0,"BMO Capital Initiates Coverage On Teva Pharmaceutical Indus with Market Perform Rating, Announces $18 Price Target",2019-03-28 06:53:00-04:00,TEVA,neutral
1222071.0,OxyContin Manufacturer Purdue Agrees to Settlement in Oklahoma Lawsuit,2019-03-26 04:30:00-04:00,TEVA,neutral
1222072.0,"SunTrust Robinson Humphrey Initiates Coverage On Teva Pharmaceutical Indus with Hold Rating, Announces $17 Price Target",2019-03-20 07:11:00-04:00,TEVA,neutral
1222073.0,Novo Nordisk Settles U.S. Patent Litigation Case On Victoza With Teva,2019-03-18 07:08:00-04:00,TEVA,negative
1222074.0,"UBS Reinstates Buy on Teva Pharmaceutical Indus, Announces $22",2019-03-07 07:11:00-05:00,TEVA,neutral
1222075.0,"Benzinga's Top Upgrades, Downgrades For March 6, 2019",2019-03-06 09:17:00-05:00,TEVA,positive
1222076.0,"Morgan Stanley Downgrades Teva Pharmaceutical Indus to Equal-Weight, Announces $17 Price Target",2019-03-06 06:31:00-05:00,TEVA,neutral
1222077.0,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,2019-03-04 11:50:00-05:00,TEVA,neutral
1222078.0,Teva Announces Launch Of Authorized Generic Of Flector Patch In United States,2019-03-01 16:08:00-05:00,TEVA,positive
1222079.0,"Mylan's Disappointing Outlook Rattles Analysts, Investors",2019-02-27 16:04:00-05:00,TEVA,negative
1222080.0,FDA Approved Teva-Branded R&D's Supplemental New Drug Application For Proair HFA Inhalation Aerosol,2019-02-26 10:29:00-05:00,TEVA,positive
1222081.0,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering",2019-02-20 07:34:00-05:00,TEVA,negative
1222082.0,Mizuho Downgrades Teva to Neutral from Buy; Lowers Price Target to $18 from $25,2019-02-20 04:25:00-05:00,TEVA,negative
1222083.0,Teva Finalizes Settlement with FTC to Resolve All Outstanding Litigation between the Parties,2019-02-20 03:54:00-05:00,TEVA,positive
1222084.0,"Teva Reports Finalization Of Its Settlement With FTC, Will Resolve All Outstanding Litigation Between Parties",2019-02-19 18:31:00-05:00,TEVA,positive
1222085.0,"FDA Commissioner Scott Gottlieb Issues Statement On New Policy To Improve Access, Foster Price Competition For Drugs Which Face Inadequate Generic Competition; FDA To Advance Added Policies To Promote This Over Next Year",2019-02-15 10:21:00-05:00,TEVA,positive
1222086.0,"Q4 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",2019-02-15 10:21:00-05:00,TEVA,neutral
1222087.0,Credit Suisse Stays Sidelined On Teva: 'Our Growth Expectations Are Below That Of The Company',2019-02-14 13:34:00-05:00,TEVA,positive
1222088.0,Teva Tanks As The Chart Shows Growing Downside Risk,2019-02-14 12:54:00-05:00,TEVA,negative
1222089.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Thurs., Feb. 14, 2019",2019-02-14 09:45:00-05:00,TEVA,positive
1222090.0,"JANA 13F Shows Cut Stakes In Teva Pharma, Jack In The Box",2019-02-14 09:43:00-05:00,TEVA,negative
1222091.0,"Benzinga's Top Upgrades, Downgrades For February 14, 2019",2019-02-14 09:09:00-05:00,TEVA,positive
1222092.0,Raymond James Upgrades Teva Pharmaceutical Indus to Outperform,2019-02-14 06:44:00-05:00,TEVA,neutral
1222093.0,58 Biggest Movers From Yesterday,2019-02-14 05:35:00-05:00,TEVA,neutral
1222094.0,42 Stocks Moving In Wednesday's Mid-Day Session,2019-02-13 12:25:00-05:00,TEVA,neutral
1222095.0,"Teva Pharmaceutical Industries shares are trading lower after the company reported Q4 EPS of $0.53, missing the $0.54 estimate and issued FY19 guidance below consensus estimates.",2019-02-13 09:39:00-05:00,TEVA,negative
1222096.0,35 Stocks Moving In Wednesday's Pre-Market Session,2019-02-13 08:47:00-05:00,TEVA,neutral
1222097.0,Teva CEO Schultz Says A Florida Plant Received An FDA Warning Letter,2019-02-13 08:22:00-05:00,TEVA,negative
1222098.0,"From Teva Earnings Conference Call: Sees Return To Growth In 2020, Cites Launhces Of Ajovy, Austedo",2019-02-13 08:05:00-05:00,TEVA,positive
1222099.0,"Teva Pharamaceuticals Sees FY19 Adj. EPS $2.20-$2.50 vs $2.81 Est., Sales $17.0B-$17.4B vs $17.93B Est.",2019-02-13 07:03:00-05:00,TEVA,neutral
1222100.0,"Teva Pharmaceutical Q4 EPS $0.53 Misses $0.54 Estimate, Sales $4.6B Beat $4.53B Estimate",2019-02-13 07:02:00-05:00,TEVA,negative
1222101.0,"13 Stocks To Watch For February 13, 2019",2019-02-13 04:30:00-05:00,TEVA,neutral
1222102.0,"Earnings Scheduled For February 13, 2019",2019-02-13 04:05:00-05:00,TEVA,neutral
1222103.0,CTI BioPharma Recieves a $10M Milestone Payment from Teva Pharma for TRISENOX,2019-02-11 07:06:00-05:00,TEVA,neutral
1222104.0,Teva Announces U.S. Launch Of A Generic Version Of Sabril (Vigabatrin),2019-02-06 11:13:00-05:00,TEVA,neutral
1222105.0,"Teva Announces Launch of ALYQ, a Generic Version of ADCIRCA in the U.S.",2019-02-06 03:57:00-05:00,TEVA,neutral
1222106.0,Teva Pharmaceutical Wins Tentative FDA Approval For Dapagliflozin,2019-02-05 12:42:00-05:00,TEVA,positive
1222107.0,Ani Pharmaceuticals Enters Asset Purchase Agreement With Teva Pharmaceuticals; Co. To Pay Teva Sum Of $16M,2019-02-01 16:59:00-05:00,TEVA,positive
1222108.0,"Optum To Cover Amgen, Eli Lilly Migraine Drugs, Exclude Teva",2019-02-01 10:35:00-05:00,TEVA,negative
1222109.0,"UPDATE: Teva Says 'If Approved, AJOVY will be the First and Only Anti-CGRP Treatment with Quarterly and Monthly Dosing Options in the European Union'",2019-02-01 06:50:00-05:00,TEVA,positive
1222110.0,Teva Pharma Reports Received Positive CHMP Opinion For AJOVY For Prophylaxis Of Migraine In Adults,2019-02-01 06:50:00-05:00,TEVA,positive
1222111.0,Teva Says Its Generic EpiPen Is Currently Available And Co. Continues To Build Supply,2019-01-31 11:50:00-05:00,TEVA,neutral
1222112.0,"UPDATE: Retailers, Drug Supply Experts Say Teva's EpiPen Generic Was Added To List Of Drugs In Shortage",2019-01-31 11:50:00-05:00,TEVA,negative
1222113.0,Retailers/Drug Supply Experts Say Teva's Generic EpiPen Is Not Available In Many US Pharmacies,2019-01-31 11:48:00-05:00,TEVA,neutral
1222114.0,"CVS Says Puts New Migraine Drugs From Teva And Eli Lilly On List Of Covered Medicines, Excludes Amgen's AIMOVIG",2019-01-25 14:28:00-05:00,TEVA,neutral
1222115.0,Teva Pharmaceutical Indus Option Alert: Feb 15 $20 Calls Sweep (18) near the Ask: 500 @ $0.75 vs 6862 OI; Earnings 2/13 Before Open Ref=$19.39,2019-01-23 15:14:00-05:00,TEVA,positive
1222116.0,"Teva Has Potential For 6% CAGR Ahead, UBS Says In Upgrade",2019-01-23 11:00:00-05:00,TEVA,neutral
1222117.0,Teva Pharmaceuticals shares are trading higher after PiperJaffray upgraded the stock from Underweight to Neutral and raised the price target from $15 to $16.,2019-01-23 09:34:00-05:00,TEVA,positive
1222118.0,"Benzinga's Top Upgrades, Downgrades For January 23, 2019",2019-01-23 09:14:00-05:00,TEVA,positive
1222119.0,"PiperJaffray Upgrades Teva Pharmaceutical Indus to Neutral, Raises Price Target to $16",2019-01-23 06:39:00-05:00,TEVA,neutral
1222120.0,UBS Upgrades Teva to Buy from Neutral; Raises Price Target to 24 Shekels from 23 Shekels,2019-01-23 04:36:00-05:00,TEVA,neutral
1222121.0,U.S. Supreme Court Rules Against Helsinn Healthcare In Patent Dispute Over Aloxi With Teva Pharmaceutical Industries,2019-01-22 10:03:00-05:00,TEVA,positive
1222122.0,UPDATE: FDA Says Side Effects Of Vigabatrin Include Permanent Vision Loss And Risk Of Suicidal Thoughts Or Actions,2019-01-16 12:38:00-05:00,TEVA,negative
1222123.0,Teva Receives FDA Approval For Generic Version Of Vigabatrin For Treating Partial Complex Seizures,2019-01-16 12:37:00-05:00,TEVA,positive
1222124.0,FDA Says Labeling For Vigabatrin Tablets Includes Boxed Warning For Permanent Vision Loss,2019-01-16 12:36:00-05:00,TEVA,negative
1222125.0,Teva Pharmaceutical shares are trading higher after Bank of America upgraded the stock from Underperform to Buy.,2019-01-03 09:47:00-05:00,TEVA,positive
1222126.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2019",2019-01-03 09:09:00-05:00,TEVA,positive
1222127.0,Bank of America Upgrades Teva Pharmaceutical Indus to Buy,2019-01-03 07:49:00-05:00,TEVA,neutral
1222128.0,"The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen",2019-01-03 07:36:00-05:00,TEVA,negative
1222129.0,"Teva, Amgen Resolve Ongoing Dispute Over Teva's Generic Cinacalet HCl Product",2019-01-03 04:12:00-05:00,TEVA,neutral
1222130.0,Teva Pharmaceutical Indus Option Alert: Jan 4 $15.5 Calls Sweep (16) near the Ask: 900 @ $0.26 vs 272 OI; Earnings 2/7 Before Open [est] Ref=$15.375,2018-12-31 14:57:00-05:00,TEVA,positive
1222131.0,Teva Pharmaceutical Indus Option Alert: Jan 18 $16 Calls Sweep (16) near the Ask: 500 @ $0.47 vs 2623 OI; Earnings 2/7 Before Open [est] Ref=$15.49,2018-12-31 13:07:00-05:00,TEVA,positive
1222132.0,Teva Highlights US Launch Of Generic Elidel Cream,2018-12-27 12:05:00-05:00,TEVA,neutral
1222133.0,Teva Pharmaceuticals shares are up 5% after the company settled its patent dispute with Neos Therapeutics.,2018-12-26 13:44:00-05:00,TEVA,negative
1222134.0,Neos Therapeutics Announces Settlement With Teva on Cotempla XR-ODT Patent Litigation; Co. Has Granted Teva Right To Manufacture Its Generic Version Of XR-ODT Beginning In 2026 Or Earlier,2018-12-26 07:31:00-05:00,TEVA,positive
1222135.0,Teva Announces FDA Approval Of First And Only Digital Inhaler With Built-In Sensors – ProAir Digihaler Inhalation Powder,2018-12-21 15:20:00-05:00,TEVA,positive
1222136.0,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",2018-12-20 07:53:00-05:00,TEVA,positive
1222137.0,"Jim Cramer Gives His Opinion On Cyberark, Ford, Teva And More",2018-12-20 07:30:00-05:00,TEVA,neutral
1222138.0,"FTC Approves Teva's Petition To Reopen, Modify Decision, Order In Case Related To Watson Purchase Of Actavis",2018-12-18 14:06:00-05:00,TEVA,positive
1222139.0,Hearing Evercore ISI Analyst Suggesting CVS Has Selected Teva's CGRP Coverage,2018-12-17 11:32:00-05:00,TEVA,neutral
1222140.0,"Teva And Celltrion On Friday Announced FDA Approval of HERZUMA, A Biosimilar To HERCEPTIN, For Treatment Of HER2-Overexpressing Breast Cancer For Certain Indications",2018-12-17 08:49:00-05:00,TEVA,negative
1222141.0,Teva Announces Phase IIIb FOCUS Study Of Fremanezumab Met All Primary And Secondary Endpoints In Adults With Migraine Who Did Not Respond To Multiple Classes Of Preventive Treatments,2018-12-17 08:02:00-05:00,TEVA,neutral
1222142.0,"Shares of generic drug makers are trading down on reports of expanded investigations into price fixing practices; Notable movers include Mylan down 3.5% Teva down 5.3%, Dr Reddy's Laboratories down 3.0%.",2018-12-10 10:13:00-05:00,TEVA,positive
1222143.0,Investigation of Generic Cartel Expands to 300 Drugs,2018-12-10 04:12:00-05:00,TEVA,positive
1222144.0,This Day In Market History: UN Partitions Palestine For Independent Jewish State,2018-11-29 09:11:00-05:00,TEVA,neutral
1222145.0,"Celltrion, Teva Report FDA Approval For TRUXIMA For Treatment Of Adult Patients For 3 Indications",2018-11-28 15:39:00-05:00,TEVA,positive
1222146.0,FDA Says Teva Issued Voluntary Recall Of All Amlodipine/Valsartan Combo Tablets,2018-11-27 16:10:00-05:00,TEVA,neutral
1222147.0,"'FDA promised a 'lower-cost option' to EpiPen, but the price isn't any lower' -STAT News",2018-11-27 12:36:00-05:00,TEVA,positive
1222148.0,Teva's Generic Version Of EpiPen Auto-Injector 0.3 mg Now Available In Limited Quantity In The United States,2018-11-27 10:06:00-05:00,TEVA,positive
1222149.0,9 Policy Catalysts For Health Care Investors To Watch Before Year's End,2018-11-25 09:35:00-05:00,TEVA,positive
1222150.0,"Hearing Appeals Court Says JNJ Can't Prevent Sales Of Generic Zytiga; Says Teva, Mylan Can Enter Market",2018-11-20 16:02:00-05:00,TEVA,neutral
1222151.0,"Jim Cramer Weighs In On Dropbox, Teva And More",2018-11-14 07:46:00-05:00,TEVA,neutral
1222152.0,"Bulls & Bears Of The Week: Apple, Disney, Ford, Target And More",2018-11-11 09:01:00-05:00,TEVA,neutral
1222153.0,"Teva To Deliver Cost Cuts, Earnings Surprise In Coming Years, Morgan Stanley Says In Upgrade",2018-11-05 12:51:00-05:00,TEVA,neutral
1222154.0,"Benzinga's Top Upgrades, Downgrades For November 5, 2018",2018-11-05 09:05:00-05:00,TEVA,positive
1222155.0,"Morgan Stanley Upgrades Teva Pharmaceutical Indus to Overweight, Announces $27 Price Target",2018-11-05 06:41:00-05:00,TEVA,negative
1222156.0,Morgan Stanley Upgrades Teva Pharmaceutical Industries to Overweight from Equal-Weight; Raises Price Target to $27 from $20,2018-11-05 03:49:00-05:00,TEVA,negative
1222157.0,76 Biggest Movers From Yesterday,2018-11-02 06:12:00-04:00,TEVA,neutral
1222158.0,56 Stocks Moving In Thursday's Mid-Day Session,2018-11-01 12:59:00-04:00,TEVA,neutral
1222159.0,Teva Pharmaceuticals shares are up 12.0% after the company beat Q3 EPS estimates and raised its FY18 EPS guidance.,2018-11-01 11:46:00-04:00,TEVA,positive
1222160.0,35 Stocks Moving In Thursday's Pre-Market Session,2018-11-01 08:04:00-04:00,TEVA,neutral
1222161.0,"Teva Raises FY18 Adj. EPS Guidance From $2.55-$2.80 To $2.80-$2.95 vs $2.78 Estimate, Narrows Sales From $18.5B-$19B To $18.6B-$19B vs $18.86B Est.",2018-11-01 07:02:00-04:00,TEVA,neutral
1222162.0,"Teva Pharmaceutical Industries Limited Q3 EPS $0.68 Beats $0.54 Estimate, Sales $4.529B Miss $4.53B Estimate",2018-11-01 07:01:00-04:00,TEVA,negative
1222163.0,"Earnings Scheduled For November 1, 2018",2018-11-01 04:15:00-04:00,TEVA,neutral
1222164.0,Judge Denies Teva Pharmaceuticals' Motion To Dismiss Corcept Therapeutics' Allegations Of Patent Infringement,2018-10-24 08:15:00-04:00,TEVA,negative
1222165.0,Corcept Therapeutics Shares Up 4% Over Last Few Mins. As Traders Circulate Court Order Doc Showing Teva Motion To Dismiss Co. Complaint Related To Generic Product Was Denied,2018-10-23 15:03:00-04:00,TEVA,negative
1222166.0,Hearing Teva Received Tentative FDA Approval For Mifepristone,2018-10-18 15:07:00-04:00,TEVA,positive
1222167.0,Mylan Announces United States Court Of Appeals Has Affirmed Prior Court Decision Finding Teva's Copaxone Patent Invalid,2018-10-12 12:29:00-04:00,TEVA,positive
1222168.0,US Appeals Court Rejects Appeal By Teva Of Ruling Invalidating Patents On MS Drug Copaxone,2018-10-12 09:56:00-04:00,TEVA,negative
1222169.0,"Teva, Celltrion Report FDA Oncologic Drugs Advisory Committee Voted Unanimously 16-0 To Recommend Approval Of CT-P10 For Treatment Of Adult Patients With 3 Proposed Indications",2018-10-10 12:31:00-04:00,TEVA,positive
1222170.0,Teva Tp Present 25-year Safety And Tolerability Data From Longest Continuous Trial Of COPAXONE For Treatment Of Relapsing Forms Of Multiple Sclerosis At 2018 ECTRIMS Annual Meeting in Berlin,2018-10-10 11:02:00-04:00,TEVA,positive
1222171.0,FDA Commissioner Scott Gottlieb Issues Statement On 'new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines',2018-10-09 11:19:00-04:00,TEVA,positive
1222172.0,Hearing Teva Phatmaceuticals Announced New Data On COPAXON(R) For Multiple Sclerosis Will Be Presented At 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis Oct 10-12,2018-10-09 10:51:00-04:00,TEVA,neutral
1222173.0,3 Headwinds Hindering Mylan,2018-10-09 09:46:00-04:00,TEVA,neutral
1222174.0,Leerink: Improving Fundamentals Drive Teva Upgrade,2018-10-01 14:01:00-04:00,TEVA,positive
1222175.0,"Benzinga's Top Upgrades, Downgrades For October 1, 2018",2018-10-01 09:05:00-04:00,TEVA,positive
1222176.0,"Goldman Calls Teva Shares 13% Pullback Over Last Week 'A Head Scratcher'; Adds Stock To Its Conviction Buy List; Reiterates Buy Rating, $30 Price Target",2018-10-01 08:37:00-04:00,TEVA,positive
1222177.0,20 Stocks Moving In Monday's Pre-Market Session,2018-10-01 08:03:00-04:00,TEVA,neutral
1222178.0,Leerink Swann Upgrades Teva Pharmaceutical Indus to Market Perform,2018-10-01 06:34:00-04:00,TEVA,neutral
1222179.0,Teva Pharmaceuticals Announces Exclusive First-To-File Launch Of A Generic Version Of Cialis In US,2018-09-27 15:03:00-04:00,TEVA,positive
1222180.0,US Judge Has Dismissed Patent Suits By Teva Against Eli Lilly Related To Its Migraine Drug,2018-09-27 14:13:00-04:00,TEVA,neutral
1222181.0,Seeing Notable Block Trade In Teva After Hours; 1M Shares at $23.86 Above Ask of $23.83,2018-09-24 16:18:00-04:00,TEVA,negative
1222182.0,"Credit Suisse Lifts Teva Price Target, Says Execution Is Key For Migraine Drug",2018-09-17 15:07:00-04:00,TEVA,positive
1222183.0,Mid-Afternoon Market Update: Dow Falls Over 50 Points; Select Income REIT Shares Spike Higher,2018-09-17 14:36:00-04:00,TEVA,positive
1222184.0,36 Stocks Moving In Monday's Mid-Day Session,2018-09-17 12:27:00-04:00,TEVA,neutral
1222185.0,Mid-Day Market Update: Senomyx Climbs Following Acquisition News; Government Properties Income Trust Shares Fall,2018-09-17 12:08:00-04:00,TEVA,positive
1222186.0,Mid-Morning Market Update: Markets Mostly Lower; Teva's Preventive Migraine Treatment Approved By FDA,2018-09-17 10:20:00-04:00,TEVA,positive
1222187.0,10 Biggest Price Target Changes For Monday,2018-09-17 09:50:00-04:00,TEVA,neutral
1222188.0,"Benzinga's Top Upgrades, Downgrades For September 17, 2018",2018-09-17 09:13:00-04:00,TEVA,positive
1222189.0,Teva's Preventive Migraine Treatment Approved By FDA,2018-09-17 09:08:00-04:00,TEVA,positive
1222190.0,"Credit Suisse Maintains Neutral on Teva Pharmaceutical Indus, Raises Price Target to $26",2018-09-17 09:06:00-04:00,TEVA,positive
1222191.0,Teva Pharmaceutical Industries Late Friday Announced FDA Approval Of AJOVYTM Injection As A Preventative Migraine Treatment,2018-09-17 08:28:00-04:00,TEVA,positive
1222192.0,BTIG Research Upgrades Teva Pharmaceutical Indus to Neutral,2018-09-17 08:06:00-04:00,TEVA,neutral
1222193.0,28 Stocks Moving In Monday's Pre-Market Session,2018-09-17 08:02:00-04:00,TEVA,neutral
1222194.0,"The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-16 14:22:00-04:00,TEVA,neutral
1222195.0,Teva Shares Spike Higher Over Last Min. Amid Report Co.'s Medis Unit Has Drawn Interest From Recipharm EMS,2018-09-12 15:00:00-04:00,TEVA,positive
1222196.0,"Acorda Therapeutics Shares Down 21.3% After Earlier Report It Has Lost An Patent Court Appeal Ruling Regarding The Drug Ampyra, Affirming A Trial Ruling In Favor Of Teva and Mylan",2018-09-10 11:44:00-04:00,TEVA,positive
1222197.0,FDA Grants Approval Of Cassipa Sublingual Film To Teva For Maintenance Treatment Of Opioid Dependence,2018-09-07 16:30:00-04:00,TEVA,positive
1222198.0,"Credit Suisse Downgrades Teva Pharmaceutical Indus to Neutral, Lowers Price Target to $23",2018-09-07 09:25:00-04:00,TEVA,positive
1222199.0,New Class of Migraine Drug Creates Four-Way Pharma Development Race,2018-09-06 15:58:00-04:00,TEVA,positive
1222200.0,"Teva Press Release Highlights $400M Debt Tender Offer, Says Is Engaging 'the Offers to reduce its total debt and decrease its overall interest expense'",2018-09-04 11:46:00-04:00,TEVA,positive
1222201.0,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,2018-08-31 15:06:00-04:00,TEVA,neutral
1222202.0,"Stocks Which Set New 52-Week High Yesterday, August 21st",2018-08-22 09:06:00-04:00,TEVA,neutral
1222203.0,"The Daily Biotech Pulse: FDA Snub For Allergan, Myriad's Q4 Beat, Mallinckrodt's Stannsoporfin",2018-08-22 08:20:00-04:00,TEVA,negative
1222204.0,"Stocks Which Set New 52-Week High Tues., Aug. 21, 2018",2018-08-21 14:50:00-04:00,TEVA,neutral
1222205.0,Teva Pharmaceutical Indus Option Alert: Oct 19 $27 Calls Sweep (18) above Ask!: 509 @ $0.865 vs 537 OI; Ref=$25.245,2018-08-20 10:12:00-04:00,TEVA,positive
1222206.0,"The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns",2018-08-17 08:15:00-04:00,TEVA,negative
1222207.0,"Antares Pharma Shares Close Up 4.1%, Up Another 6.1% After Hours On News Its Partner, Teva, Received FDA Approval For Its Generic Epinephrine, For Which Antares Has the Exclusive License to Market In The U.S.",2018-08-16 17:05:00-04:00,TEVA,positive
1222208.0,Teva Wins FDA Approval For Generic Epinephrine,2018-08-16 16:00:00-04:00,TEVA,positive
1222209.0,"FDA Statement Confirms Approval of Teva's Generic Version of Mylan's Epipen; Mylan Shares -0.4%, Teva +6.2%; BZ NOTE: Antares Pharma Has Exclusive License To Market Teva's Epinephrine in the U.S.",2018-08-16 13:09:00-04:00,TEVA,positive
1222210.0,Hearing Teva Gets FDA Approval For Generic Epinephrine,2018-08-16 12:55:00-04:00,TEVA,positive
1222211.0,Teva Pharmaceuticals shares are up 4.4% and Regeneron shares are trading up 2.5% after the companies reported positive results from  a Phase 3 study of fasinumab for osteoarthritis pain.,2018-08-16 12:29:00-04:00,TEVA,positive
1222212.0,Regeneron and Teva Announce Phase 3 Fasinumab Met Both Co-Primary Endpoints And All Secondary Endpoints,2018-08-16 07:02:00-04:00,TEVA,neutral
1222213.0,"Q2 13F Roundup: How Buffett, Einhorn, Loeb And Others Adjusted Their Portfolio",2018-08-15 10:23:00-04:00,TEVA,neutral
1222214.0,"13F Filing From Berkshire Hathaway Shows Reduced Stake In Charter Communications, Moody's, Phillips 66, United Continental; Raised Stake In Bank of New York Mellon, General Motors, Goldman Sachs, Southwest Airlines, Teva Pharma, US Bancorp",2018-08-14 16:20:00-04:00,TEVA,positive
1222215.0,Trump Says Administration Will Be Making an Announcement Next Week Regarding Reducing Drug Prices,2018-08-07 20:07:00-04:00,TEVA,neutral
1222216.0,Teva Pharmaceutical Industries shares are up 3% after  the company announced its GRANIX injection has been approved by the FDA for a vial presentation in pediatric neutropenia patients.,2018-08-06 11:02:00-04:00,TEVA,positive
1222217.0,"Barclays Maintains Equal-Weight on Teva Pharmaceutical Indus, Raises Price Target to $23",2018-08-06 08:59:00-04:00,TEVA,neutral
1222218.0,Teva Pharma Announces its GRANIX Has Been Approved by the FDA For a New Vial Presentation,2018-08-06 08:10:00-04:00,TEVA,positive
1222219.0,"Morgan Stanley Maintains Equal-Weight on Teva Pharmaceutical Indus, Raises Price Target to $20",2018-08-03 07:27:00-04:00,TEVA,neutral
1222220.0,"UPDATE: Acorda Says Has Signed Interim Deal With Teva For Ampyra Time Period Until Aug. 31, 2018",2018-08-03 07:18:00-04:00,TEVA,neutral
1222221.0,"Acorda 8-K Shows Updates On Litigation With Mylan, Teva, West-Ward Pharma, Hikma Related To Ampyra Orange Book-Listed Patents: Entered Into Conditional Settlement Deal",2018-08-03 07:17:00-04:00,TEVA,negative
1222222.0,75 Biggest Movers From Yesterday,2018-08-03 06:10:00-04:00,TEVA,neutral
1222223.0,65 Stocks Moving In Thursday's Mid-Day Session,2018-08-02 12:26:00-04:00,TEVA,neutral
1222224.0,32 Stocks Moving In Thursday's Pre-Market Session,2018-08-02 08:05:00-04:00,TEVA,neutral
1222225.0,"UPDATE: Teva Raises FY18 Guidance From $2.40-$2.65 To $2.55-$2.80 vs $2.69 Estimate, Free Cash Flow From $3B-$3.2B To $3.2B-$3.4B",2018-08-02 07:04:00-04:00,TEVA,positive
1222226.0,Teva Raises FY18 Guidance,2018-08-02 07:03:00-04:00,TEVA,neutral
1222227.0,Teva Pharmaceutical Sales $4.701B Miss $4.74B Estimate,2018-08-02 07:02:00-04:00,TEVA,negative
1222228.0,Teva Pharmaceutical Indus Q2 EPS $0.78 Beats $0.64 Estimate,2018-08-02 07:02:00-04:00,TEVA,neutral
1222229.0,"Earnings Scheduled For August 2, 2018",2018-08-02 04:48:00-04:00,TEVA,neutral
1222230.0,Teva Pharmaceutical's Earnings Preview,2018-08-01 15:43:00-04:00,TEVA,neutral
1222231.0,Teva Pharmaceutical Indus Option Alert: Jan 18 $24 Calls Sweep (2) near the Ask: 643 @ $2.641 vs 9469 OI; Earnings 8/2 Before Open Ref=$24.0,2018-08-01 13:46:00-04:00,TEVA,positive
1222232.0,"UPDATE: Acorda, Alkermes v. Roxane Labs, Mylan, Teva Doc Shows 'On July 23, 2018, Acorda notified the court that ""Acorda plans to seek an emergency injunction on July 25, 2018 absent a change in circumstances.""'",2018-07-25 11:29:00-04:00,TEVA,negative
1222233.0,"Hearing Acorda Loses Bid For Emergency Order Blocking Ampyra Copy, Co. Is Awaiting Decision On Validity Of Ampyra Patents",2018-07-25 11:19:00-04:00,TEVA,negative
1222234.0,"Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4",2018-07-17 08:37:00-04:00,TEVA,neutral
1222235.0,Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall Of Valsartan And Valsartan Hydrochlorothiazide Tablets Due To Detection Of Trace Amounts Of Unexpected Impurity Found In An Active Pharmaceutical Agreement Manufactured By Zhejiang Huahai,2018-07-16 16:37:00-04:00,TEVA,positive
1222236.0,10 Biggest Price Target Changes For Monday,2018-07-16 09:34:00-04:00,TEVA,neutral
1222237.0,"Cantor Fitzgerald Maintains Neutral on Teva Pharmaceutical Indus, Raises Price Target to $25",2018-07-16 08:19:00-04:00,TEVA,neutral
1222238.0,Analyst: Opioid Legislation Likely Stalled In Senate Until After November Elections,2018-07-14 13:54:00-04:00,TEVA,negative
1222239.0,"Cantor Fitzgerald Raises Teva Price Target From $18 To $25 Due To Solid Execution, Stable Generic Drug Pricing And Expected Approval Of fremanezumab Driving Multiple Expansion",2018-07-13 11:46:00-04:00,TEVA,positive
1222240.0,"Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings",2018-07-12 10:28:00-04:00,TEVA,neutral
1222241.0,Teva Announces Launch of a Generic Version of Uceris In The U.S.,2018-07-09 10:47:00-04:00,TEVA,neutral
1222242.0,"Cosmo Pharmaceuticals Announced FDA Has Approved TEVA's Generic Version Of Uceris, Actavis; Co. Says It Will Continue To Defend And Enforce Patent Rights On Uceris, Says If Teva Decides To Launch At Risk, It Would Expose Teva To Pay Significant Damages",2018-07-06 11:51:00-04:00,TEVA,negative
1222243.0,A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year,2018-07-05 12:25:00-04:00,TEVA,neutral
1222244.0,Wells Fargo Upgrades Teva Pharmaceutical Indus to Market Perform,2018-06-18 09:31:00-04:00,TEVA,positive
1222245.0,Teva  Says Primary Endpoint Of Mean Change From Baseline In Monthly Avg. Number Of Cluster Headache Attacks In ENFORCE Phase III Program Is Unlikely To Be Met,2018-06-15 08:02:00-04:00,TEVA,negative
1222246.0,Teva Pharmaceutical Indus Option Alert: Aug 17 $27 Calls Sweep (31) near the Ask: 1643 @ $0.661 vs 265 OI; Earnings 8/2 Before Open [est] Ref=$23.96,2018-06-12 10:09:00-04:00,TEVA,positive
1222247.0,Teva Pharmaceutical Indus Option Alert: Fri $23.5 Calls Sweep (2) near the Ask: 1000 @ $0.5 vs 1928 OI; Earnings 8/2 Before Open [est] Ref=$23.7436,2018-06-12 09:40:00-04:00,TEVA,positive
1222248.0,"Corcept Therapeutics Is 'Fairly Valued,' Stifel Says In Downgrade",2018-05-31 12:52:00-04:00,TEVA,neutral
1222249.0,"Benzinga's Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck's Cancer Drug Review Extended",2018-05-25 09:19:00-04:00,TEVA,negative
1222250.0,"Amarin Announces Patent Litigation Settlement With Teva, Allowing Teva To Begin Selling Its Generic Version of Vascepa In the U.S. On August 9, 2029 or Earlier Under 'Certain Circumstances'",2018-05-24 16:36:00-04:00,TEVA,positive
1222251.0,"Jim Cramer Gives His Opinion On Blue Apron, Teva And More",2018-05-24 07:33:00-04:00,TEVA,neutral
1222252.0,"Teva Pharma Confirms PDUFA Date For Fremanezumab As Sept. 16, '18",2018-05-23 08:06:00-04:00,TEVA,neutral
1222253.0,Cantor Fitzgerald: 18 Drug Companies With Catalysts Worth Watching,2018-05-19 16:10:00-04:00,TEVA,positive
1222254.0,Warren Buffett Pushing More Cash To Equities; 'Big 5' Stocks Still At The Top,2018-05-16 15:19:00-04:00,TEVA,positive
1222255.0,"Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolio",2018-05-16 11:38:00-04:00,TEVA,neutral
1222256.0,26 Stocks Moving In Wednesday's Pre-Market Session,2018-05-16 08:14:00-04:00,TEVA,neutral
1222257.0,"13F From Buffett's Berkshire Shows Raised Stakes In Apple, Teva, Cut Stakes In Phillips 66, Verisk Analytics, Dissolved Stakes In IBM, Graham Holdings",2018-05-15 16:22:00-04:00,TEVA,negative
1222258.0,Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association,2018-05-15 11:06:00-04:00,TEVA,neutral
1222259.0,"Insider Buys Of The Week: ADS, Tesla, Teva And More",2018-05-13 09:52:00-04:00,TEVA,neutral
1222260.0,Hearing Teva Canada Launches A Generic Version Of Allergan's Restasis,2018-05-10 09:33:00-04:00,TEVA,neutral
1222261.0,Teva Shares Down ~3% As Last Night's 10-Q Filing Discloses That The Co. Is Involved In Govt. Investigations And Litigation From The Marketing And Promotion Of Its Pharmaceutical Products In The U.S.,2018-05-04 10:15:00-04:00,TEVA,positive
1222262.0,"Benzinga Pro's Most-Searched Tickers For Morning Of Fri., May 4, 2018",2018-05-04 09:15:00-04:00,TEVA,neutral
1222263.0,Benzinga Pro's 5 Stocks To Watch Today,2018-05-03 09:31:00-04:00,TEVA,neutral
1222264.0,27 Stocks Moving In Thursday's Pre-Market Session,2018-05-03 08:04:00-04:00,TEVA,neutral
1222265.0,Teva Raises FY18 Adj. EPS Guidance From $2.25-$2.50 To $2.40-$2.65,2018-05-03 07:01:00-04:00,TEVA,neutral
1222266.0,Teva Raises FY18 Sales $18.3-$18.8B To $18.5-$19B,2018-05-03 07:01:00-04:00,TEVA,neutral
1222267.0,"Teva Pharmaceutical Indus Q1 EPS $0.94 Beats $0.66 Estimate, Sales $5.1B Beat $4.8B Estimate",2018-05-03 07:00:00-04:00,TEVA,neutral
1222268.0,"Earnings Scheduled For May 3, 2018",2018-05-03 05:15:00-04:00,TEVA,neutral
1222269.0,"Teva Pharma Reports Presentation Of Long-Term Data Showing Efficacy, Safety Of COPAXONE 40 mg/mL",2018-04-27 15:50:00-04:00,TEVA,positive
1222270.0,"Saw Big Volume Spike, Volatility In Teva Amid Report Generic-Drug Cos. Facing First Charges In US Probe",2018-04-24 15:58:00-04:00,TEVA,negative
1222271.0,Goldman Sachs Neutral On Alder Biopharma As Launch Of Migraine Treatment Approaches,2018-04-24 12:49:00-04:00,TEVA,neutral
1222272.0,Teva Shares Tick Higher Over Last Min. Following Block Trade Of 1.6M Shares At $17.52/Share,2018-04-19 14:35:00-04:00,TEVA,positive
1222273.0,"UPDATE: Teva, P&G Separation Of PGT Healthcare To Take Place On Jul. 1, '18",2018-04-19 07:04:00-04:00,TEVA,neutral
1222274.0,"Teva Reports Co., P&G Have Agreed To Terminate PGT Healthcare Partnership To Market OTC Medicines",2018-04-19 07:04:00-04:00,TEVA,positive
1222275.0,"P&G Acquires Consumer Health Business of Merck KGaA, Darmstadt, Germany",2018-04-19 03:36:00-04:00,TEVA,neutral
1222276.0,Mylan Inks Deal With Mapi Pharma For Multiple Sclerosis Drug,2018-04-12 11:05:00-04:00,TEVA,neutral
1222277.0,"Egalet 8-K Shows Co. Filed Patent Infringement Suit On Apr. 4 Against Teva, For One Of Co.'s ARYMO ER Patents Listed Orange Book, Patent No. '402",2018-04-05 06:10:00-04:00,TEVA,negative
1222278.0,"Teva, GlaxoSmithKline Shares Unaffected Following Earlier Circulation Of Court Ruling Which Showed Teva Won Reversal Of $235M Drug Patent Verdict",2018-03-28 15:22:00-04:00,TEVA,positive
1222279.0,Teva Announces the Launch of a Generic Version of Lialda in the United States,2018-03-26 14:49:00-04:00,TEVA,positive
1222280.0,"Teva Submits an NDA to the FDA Requesting Approval to Market Generic HETLIOZ, Says 6 of Vanda Pharma's Patents Which Expire in 2034 are Unenforceable",2018-03-26 07:07:00-04:00,TEVA,positive
1222281.0,Teva Announces the Launch of a Generic Version of ALOXI in the United States,2018-03-23 13:27:00-04:00,TEVA,positive
1222282.0,"Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish",2018-03-22 12:18:00-04:00,TEVA,positive
1222283.0,Trump Says He's Considering Litigation Against Drug Co.'s In Opioid Crisis,2018-03-19 14:52:00-04:00,TEVA,negative
1222284.0,Corcept Therapeutics Files Lawsuit Against Teva Pharmaceuticals for Infringement of Korlym Patents,2018-03-15 17:00:00-04:00,TEVA,negative
1222285.0,TEVA Option Alert: Apr 20 $20 Puts Sweep (24) at the Bid: 987 @ $1.48 vs 825 OI; Ref=$19.1,2018-03-09 10:14:00-05:00,TEVA,positive
1222286.0,Height Casts 65% Odds That Congress Rolls Back Pharma Discounts,2018-03-07 11:31:00-05:00,TEVA,neutral
1222287.0,"TEVA Option Alert: Jan 18, 2019 $15 Puts at the Ask: 1500 @ $1.22 vs 47860 OI; Ref=$19.16",2018-03-06 15:31:00-05:00,TEVA,positive
1222288.0,"Morgan Stanley: As Generic Competitors Falter, Mylan Is Worth A Shot",2018-03-06 10:52:00-05:00,TEVA,positive
1222289.0,"Teva Pharma and Natco Pharma Submit ANDAs to the FDA Requesting Permission to Manufacture Generic Sovaldi, Argue Gilead's Patents are Not Valid",2018-02-27 06:32:00-05:00,TEVA,negative
1222290.0,"Shares of Teva Pharma Fall After Buffett Says Berkshire's Investment in the Company Was Made by One of His Investment Deputies, Todd Combs or Ted Weschler",2018-02-26 08:23:00-05:00,TEVA,positive
1222291.0,"Outside Of Apple, Here Are 6 Other Stocks Warren Buffett Bought In Q4",2018-02-20 17:09:00-05:00,TEVA,neutral
1222292.0,"Teva Shares Down 4% Midday Tues., Have Pulled Back From $21 Level; Earlier (Just Before Noon EST) Saw 2 Notable Block Trades: ~855K Shares At $20.42, ~656K Shares At $20.41",2018-02-20 14:42:00-05:00,TEVA,positive
1222293.0,How McKesson Will Stand The Test Of Amazon,2018-02-20 11:06:00-05:00,TEVA,positive
1222294.0,Teva Announces Exclusive Launch of Two Strengths of a Generic Version of Solodyn in the United States,2018-02-20 11:03:00-05:00,TEVA,positive
1222295.0,Teva Announces U.S. Launch of QVAR RediHaler Inhalation Aerosol,2018-02-16 11:41:00-05:00,TEVA,neutral
1222296.0,The Pros And Cons Of Trading On 13F Filing Disclosures,2018-02-16 08:55:00-05:00,TEVA,neutral
1222297.0,46 Biggest Movers From Yesterday,2018-02-16 05:19:00-05:00,TEVA,neutral
1222298.0,"Q4 13F Roundup: How Buffett, Einhorn, Loeb, And Others Adjusted Their Portfolio",2018-02-15 13:43:00-05:00,TEVA,neutral
1222299.0,40 Stocks Moving In Thursday's Mid-Day Session,2018-02-15 12:11:00-05:00,TEVA,neutral
1222300.0,22 Stocks Moving In Thursday's Pre-Market Session,2018-02-15 08:41:00-05:00,TEVA,neutral
1222301.0,Benzinga Pro's 5 Stocks To Watch Today,2018-02-15 08:02:00-05:00,TEVA,neutral
1222302.0,"10 Stocks To Watch For February 15, 2018",2018-02-15 04:47:00-05:00,TEVA,neutral
1222303.0,8 Stocks Moving In Wednesday's After-Hours Session,2018-02-14 17:33:00-05:00,TEVA,neutral
1222304.0,UPDATE: 13F From Buffett's Berkshire Shows New ~19M Share Stake In Teva,2018-02-14 16:46:00-05:00,TEVA,positive
1222305.0,Teva Shares Spike Higher As Hearing Berkshire Hathaway Added Stake,2018-02-14 16:10:00-05:00,TEVA,positive
1222306.0,Teva Says its Planning to Launch a Second Generic Copaxone in 2018,2018-02-13 07:38:00-05:00,TEVA,neutral
1222307.0,"Teva's 'Achievable' 2018 Outlook, Restructuring Plan Trigger Credit Suisse Upgrade",2018-02-12 09:52:00-05:00,TEVA,positive
1222308.0,"Benzinga's Top Upgrades, Downgrades For February 12, 2018",2018-02-12 09:33:00-05:00,TEVA,positive
1222309.0,Teva Announces U.S. Launch of QVAR RediHaler Inhalation Aerosol,2018-02-12 08:10:00-05:00,TEVA,neutral
1222310.0,Teva Announces US Launch of QVAR RediHaler Inhalation Aerosol,2018-02-12 08:03:00-05:00,TEVA,neutral
1222311.0,Credit Suisse Upgrades Teva Pharmaceutical Indus to Outperform,2018-02-12 06:57:00-05:00,TEVA,positive
1222312.0,Credit Suisse Upgrades Teva to Outperform from Neutral; Raises PT to $23 from $20 -Reuters,2018-02-12 04:00:00-05:00,TEVA,positive
1222313.0,Capital Research Global Investors Reports 9.7% Stake In TEva,2018-02-09 14:03:00-05:00,TEVA,neutral
1222314.0,"Leerink Swann Maintains Underperform on Teva Pharmaceutical Indus, Lowers price target to $16.00",2018-02-09 10:17:00-05:00,TEVA,negative
1222315.0,"Benzinga's Top Upgrades, Downgrades For February 9, 2018",2018-02-09 10:17:00-05:00,TEVA,positive
1222316.0,Teva Announces Launch of Generic Syprine in the United States,2018-02-09 09:01:00-05:00,TEVA,positive
1222317.0,"Deutsche Bank Maintains Hold on Teva Pharmaceutical Indus, Lowers price target to $18.00",2018-02-09 08:53:00-05:00,TEVA,negative
1222318.0,PiperJaffray Downgrades Teva Pharmaceutical Indus to Underweight,2018-02-09 06:37:00-05:00,TEVA,neutral
1222319.0,46 Biggest Movers From Yesterday,2018-02-09 04:36:00-05:00,TEVA,neutral
1222320.0,45 Stocks Moving In Thursday's Mid-Day Session,2018-02-08 12:25:00-05:00,TEVA,neutral
1222321.0,Teva Pharmaceuticals Shares Down 9.9% After Co. Guided FY18 Sales and Earnings Below Consensus,2018-02-08 12:23:00-05:00,TEVA,positive
1222322.0,"Teva CEO On European Business, Says They Have A 'Very Good Situation' In General; Good Situation IN Growth Markets Outside Of Venezuela",2018-02-08 10:23:00-05:00,TEVA,positive
1222323.0,Seeing Notable Block Trade In Teva Of 1.1M Shares At $19.10/Share,2018-02-08 10:20:00-05:00,TEVA,negative
1222324.0,"Teva CEO Schultz Says They Can't Guarantee Growth In 2019, But 'For Sure' In 2020",2018-02-08 10:18:00-05:00,TEVA,positive
1222325.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-02-08 08:03:00-05:00,TEVA,neutral
1222326.0,"Teva Sees FY18 Adj. EPS $2.25-$2.50 vs $2.94 Est., Sales $18.3B-$18.8B vs $19.3B Est.",2018-02-08 07:03:00-05:00,TEVA,neutral
1222327.0,"Teva Reports Q4 Adj. EPS $0.93 vs $0.76 Est., Sales $5.5B vs $5.31B Est.",2018-02-08 07:03:00-05:00,TEVA,neutral
1222328.0,"Earnings Scheduled For February 8, 2018",2018-02-08 04:36:00-05:00,TEVA,neutral
1222329.0,TD Ameritrade Investors Had A Record-Breaking January,2018-02-06 17:40:00-05:00,TEVA,neutral
1222330.0,Investor Movement Index January Summary,2018-02-06 13:24:00-05:00,TEVA,neutral
1222331.0,BioDelivery Sciences Announces BELBUCA Patent Litigation Settlement Agreement with Teva,2018-02-06 07:14:00-05:00,TEVA,positive
1222332.0,Teva's Fremanezumab Marketing Authorization Application is Accepted by the European Medicines Agency,2018-02-02 07:04:00-05:00,TEVA,positive
1222333.0,"Raymond James Out On Teva, Says Full Execution Of The Co.'s Strategies In Mid-208 May Help Solidfy Post 2020 Growth Story, But See Little Upside From Current Levels",2018-02-01 14:24:00-05:00,TEVA,positive
1222334.0,Teva S-3 Shows Registration For $5B Debt Securities Offering,2018-01-29 17:40:00-05:00,TEVA,negative
1222335.0,"Jana Partners Q4 Letter Details New Stakes, Success Of Activist Positions",2018-01-25 13:49:00-05:00,TEVA,positive
1222336.0,Teva's Asthma Therapy Reslizumab Fails In Late-Stage Studies,2018-01-23 10:59:00-05:00,TEVA,negative
1222337.0,Vetr Community Upgrades Teva Pharmaceuticals,2018-01-22 16:48:00-05:00,TEVA,neutral
1222338.0,Watching Shares Of Teva Pharma As It's Reported That Jana Mentions New Stake In The Co. In Q4 Letter,2018-01-22 10:14:00-05:00,TEVA,positive
1222339.0,Teva's Phase III Study of Reslizumab Did Not Meet its Primary Endpoint,2018-01-22 08:05:00-05:00,TEVA,neutral
1222340.0,Hearing Justice Dept. Is Conducting Sweeping Generic Price-Fixing Probe,2018-01-19 11:24:00-05:00,TEVA,positive
1222341.0,Hearing BTIG Downgrades Teva From Buy To Neutral As The Firm Believes Shares Are Fairly Valued,2018-01-18 13:06:00-05:00,TEVA,positive
1222342.0,Mid-Morning Market Update: Markets Edge Lower; Morgan Stanley Beats Q4 Estimates,2018-01-18 10:09:00-05:00,TEVA,negative
1222343.0,"Traders Attributing Weakness In Endo Int'l., Teva, Mylan To Earlier NY Times Article 'Fed Up With Drug Companies, Hospitals Decide to Start Their Own'",2018-01-18 10:05:00-05:00,TEVA,negative
1222344.0,CTI BioPharma Says Expects to Receive $10M Milestone Payment in February for TRISENOX from Teva,2018-01-18 06:18:00-05:00,TEVA,neutral
1222345.0,Teva Pharmaceuticals Monday Reported FDA Approval For TRISENOX,2018-01-16 09:47:00-05:00,TEVA,positive
1222346.0,"Moody's Downgrades Teva To BA2, Outlook Stable",2018-01-12 13:58:00-05:00,TEVA,positive
1222347.0,13D/A Filing Shows Allergan Reporting 6.8% Stake in Teva Pharmaceuticals,2018-01-12 12:18:00-05:00,TEVA,neutral
1222348.0,"Cantor Out With Note On Endo, Says Oxymorphone Subpoena May Not Hurt That Much And Is Isolated To Endo For Now, But More Co.'s Could Be The Target To Investigations Over Time Including Teva, Mylan, Impax, Mallinckrodt, Allergan",2018-01-11 11:18:00-05:00,TEVA,positive
1222349.0,Teva's Cost-Cutting Plan Nets A Mizuho Upgrade,2018-01-09 10:56:00-05:00,TEVA,neutral
1222350.0,"Benzinga's Top Upgrades, Downgrades For January 9, 2018",2018-01-09 09:29:00-05:00,TEVA,positive
1222351.0,"The Market In 5 Minutes: Alabama, Saban Win Historic National Title, Samsung's Record Quarter, Under Armour Downgrade",2018-01-09 09:01:00-05:00,TEVA,positive
1222352.0,Mizuho Upgrades Teva Pharmaceutical Indus to Buy,2018-01-09 06:37:00-05:00,TEVA,neutral
1222353.0,Mizuho Upgrades Teva to Buy from Neutral; Raises PT to $23 from $16 -Reuters,2018-01-09 04:44:00-05:00,TEVA,neutral
1222354.0,"UPDATE: Alder Agreed To Withdraw Appeal With European Patent Office In Opposition To Teva; Co. Will Immediately Pay $25M To Teva With Another $25M Payment Upon Approval Of Eptinezumab BLA, 2 $75M Milestone Payments And 5-7% Royalty",2018-01-08 12:14:00-05:00,TEVA,positive
1222355.0,Teva Highlights Global License Deal With Alder BioPharma In Field Of Anti-CGRP-Based Therapy,2018-01-08 08:48:00-05:00,TEVA,neutral
1222356.0,"New Year's Benzinga Bulls & Bears: Apple, Disney, Netflix And More",2018-01-07 13:32:00-05:00,TEVA,neutral
1222357.0,Teva Vs Mylan: Wells Fargo Weighs In,2018-01-05 13:43:00-05:00,TEVA,positive
1222358.0,"Benzinga's Top Upgrades, Downgrades For January 5, 2018",2018-01-05 09:11:00-05:00,TEVA,positive
1222359.0,"The Market In 5 Minutes: Nonfarm Payrolls Miss Estimates, Apple's Safari Patch, Kalanick's Reduced Uber Stake",2018-01-05 09:00:00-05:00,TEVA,negative
1222360.0,Wells Fargo Downgrades Teva Pharmaceutical Indus to Underperform,2018-01-05 07:07:00-05:00,TEVA,positive
1222361.0,"Benzinga's Top Upgrades, Downgrades For January 4, 2018",2018-01-04 09:51:00-05:00,TEVA,positive
1222362.0,Citigroup Upgrades Teva Pharmaceutical Indus to Buy,2018-01-04 07:28:00-05:00,TEVA,neutral
1222363.0,"Leerink Initiates Coverage On Teva Pharmaceutical Indus with Underweight Rating, Announces $15.00 Price Target",2018-01-02 17:02:00-05:00,TEVA,neutral
1222364.0,Teva Announces Launch Of Generic Estrace Cream In U.S.,2018-01-02 14:26:00-05:00,TEVA,neutral
1222365.0,"Several Biotechs Higher Tuesday Amid Jefferies Mention Of Price Increases In Effect; Insys +13.21%, Synergy Pharmaceuticals +6.72%, Allergan +3.22%, Horizon Pharma +0.99%, Supernus Pharma +0.25%, Teva Pharma +0.53%; Collegium An Outlier, Down 0.64%",2018-01-02 12:26:00-05:00,TEVA,neutral
1222366.0,"Among The Market's Movers And Shakers, Who's Bullish And Who's Bearish For 2018?",2017-12-29 14:08:00-05:00,TEVA,positive
1222367.0,TEVA Option Alert: Jan 19 $20 Calls Above Ask!: 5500 @ $0.57 vs 34707 OI; Ref=$19.04,2017-12-29 09:57:00-05:00,TEVA,positive
1222368.0,Teva Pharma Reports Exclusive Launch Of Generic Version Of Reyataz In US,2017-12-27 09:00:00-05:00,TEVA,positive
1222369.0,"Earlier Chicago Tribune Report Detailed 5 Illinois Counties Suing Drug Cos. Over Opioid Abuses; Shares Of Cos. Mentioned Seem Largely Unaffected: TEVA +5.3%, ABT -0.33%, JNJ +0.03%, ENDP +0.12%",2017-12-21 14:42:00-05:00,TEVA,negative
1222370.0,"Cantor Says They Like Teva's Stock And Believe Co. Has A Lot Of Value To Be Unlocked, But Firm Says It's Hard To Recommend Shares Until Permanent Leadership Comes In; Rates Teva Neutral With $10 PT",2017-12-18 12:47:00-05:00,TEVA,positive
1222371.0,TEVA TEVA Option Alert: Fri $17.5 Calls Sweep (5) at the Ask: 500 @ $1.101 vs 13788 OI; Ref=$18.52,2017-12-18 09:33:00-05:00,TEVA,positive
1222372.0,Teva Pharma's Biologics License Application for Fremanezumab is Accepted by the FDA and is Granted Fast Track Designation,2017-12-18 08:06:00-05:00,TEVA,positive
1222373.0,TEVA Option Alert: Dec 22 $17.5 Calls Sweep (2) at the Bid: 800 @ $1.0 vs 10661 OI; Ref=$18.285,2017-12-15 15:19:00-05:00,TEVA,positive
1222374.0,Credit Suisse Upgrades Teva After Job Cuts Announced,2017-12-15 12:51:00-05:00,TEVA,positive
1222375.0,"Earlier Today, Morgan Stanley Upgraded Teva Pharmaceutical to Equal-Weight",2017-12-15 12:07:00-05:00,TEVA,neutral
1222376.0,Seeing Notable Block Trade In Teva Of 933K Shars At $18.55/Share,2017-12-15 11:24:00-05:00,TEVA,negative
1222377.0,Goldman Sachs: Now Is The Time To Get In On Teva's Turnaround,2017-12-15 11:01:00-05:00,TEVA,neutral
1222378.0,Credit Suisse Upgrades Teva Pharmaceutical Indus to Neutral,2017-12-15 09:52:00-05:00,TEVA,positive
1222379.0,Teva Pharma Reports Exclusive Launch Of Generic Version Of Viread In US,2017-12-15 09:16:00-05:00,TEVA,positive
1222380.0,"Benzinga's Top Upgrades, Downgrades For December 15, 2017",2017-12-15 08:57:00-05:00,TEVA,positive
1222381.0,Goldman Sachs Upgrades Teva Pharmaceutical Indus to Buy,2017-12-15 08:23:00-05:00,TEVA,neutral
1222382.0,32 Biggest Movers From Yesterday,2017-12-15 05:43:00-05:00,TEVA,neutral
1222383.0,32 Stocks Moving In Thursday's Mid-Day Session,2017-12-14 12:44:00-05:00,TEVA,neutral
1222384.0,"Oppenheimer Out With Color On Teva's Earlier Jobs Cut Announcement, Says They Remain On Sideline As They See A Fair Degree of Execution Risk; Sees A Protracted Turnaround With Low Growth/High Leverage For Next Several Years",2017-12-14 12:39:00-05:00,TEVA,negative
1222385.0,TEVA Option Alert: Jan 19 $17.5 Calls at the Ask: 500 @ $1.2 vs 39059 OI; Ref=$17.67,2017-12-14 10:04:00-05:00,TEVA,positive
1222386.0,9 Technical Levels To Watch From Thurs. Morning's PreMarket Prep,2017-12-14 09:12:00-05:00,TEVA,neutral
1222387.0,22 Stocks Moving In Thursday's Pre-Market Session,2017-12-14 08:22:00-05:00,TEVA,neutral
1222388.0,Teva Says Total Cost Base To Be Reduced By $3B By End Of 2019,2017-12-14 07:04:00-05:00,TEVA,neutral
1222389.0,Teva Suspends Dividend On Ordinary Shares And ADSs,2017-12-14 07:04:00-05:00,TEVA,positive
1222390.0,"Teva To Reduce Workforce By 25%, Over 14,000 Positions Reduced Globally Over Next 2 Years",2017-12-14 07:03:00-05:00,TEVA,neutral
1222391.0,"Lightning Round: Jim Cramer Advises His Viewers On Teva, Snap And More",2017-12-14 07:01:00-05:00,TEVA,neutral
1222392.0,"Israeli Prime Minister Netanyahu Says He Spoke With Teva Pharma Pres, CEO Kaare Schultz And Asked Co. Job Cuts In Israel Be Kept To A Minimum",2017-12-14 06:30:00-05:00,TEVA,negative
1222393.0,Israel Labour Federation Is Calling For Half-Day General Strike For Sunday Over Expected Teva Layoffs,2017-12-13 13:07:00-05:00,TEVA,negative
1222394.0,"Teva to Host Conf. Call to Discuss Restructuring Plan and Additional Measures to Improve Its Business and Financial Performance at 8:00 a.m. ET on Dec. 14, 2017",2017-12-13 11:30:00-05:00,TEVA,positive
1222395.0,Teva Shares Volatile Several Mins. After 6-K Filing Showing Resignation Of Board Member Yitzhak Peterburg Due To 'Personal Reasons',2017-12-12 12:48:00-05:00,TEVA,neutral
1222396.0,"Guggenheim Earlier Initiated Coverage On Teva Pharmaceutical with Neutral Rating, Announced $16.00 Price Target",2017-12-12 10:35:00-05:00,TEVA,neutral
1222397.0,Mylan Reports Teva Dismissed Litigation After Co. Won Court Ruling On Teva's Cold Filtration Patents For Copaxone 40 mg/mL,2017-12-11 12:17:00-05:00,TEVA,positive
1222398.0,Traders Circulating Recent Globes Israel Article 'Exclusive: Teva to fire 500 managers in Israel',2017-12-11 10:15:00-05:00,TEVA,negative
1222399.0,Teva Reports Exclusive Launch Of Generic Viagra Tablets In US,2017-12-11 09:18:00-05:00,TEVA,positive
1222400.0,"Hearing Teva May Cut Up To 10,000 Jobs Globally",2017-12-08 10:41:00-05:00,TEVA,negative
1222401.0,TEVA Option Alert: Dec 15 $14.5 Calls Sweep (9) at the Bid: 1140 @ $0.481 vs 1188 OI; Ref=$14.32,2017-12-06 15:20:00-05:00,TEVA,positive
1222402.0,Seeing Notable Block Trade In Teva Pharmaceuticals; 2.4M Shares At $15.26,2017-12-01 16:50:00-05:00,TEVA,negative
1222403.0,"Alibaba, JPMorgan, Teva: 'Fast Money' Picks For December 1",2017-12-01 07:39:00-05:00,TEVA,neutral
1222404.0,Watching Generic Drug Makers Following CNBC Article 'Amazon is in exploratory talks with generic-drug makers',2017-11-30 17:00:00-05:00,TEVA,positive
1222405.0,Notable Block Trade In Teva Pharmaceuticals After-hours; 2M Shares At $14.82 Above the Ask Of $14.81,2017-11-30 16:51:00-05:00,TEVA,negative
1222406.0,TEVA Option Alert: Jan 19 $15 Calls Sweep (28) at the Ask: 1402 @ $1.091 vs 34970 OI; Ref=$14.79,2017-11-29 12:17:00-05:00,TEVA,positive
1222407.0,Pre-Market Opening NYSE Imbalance: Square 282k Shares To Sell; Teva 156k Shares To Buy,2017-11-28 08:52:00-05:00,TEVA,positive
1222408.0,Seeing Notable Block Trade In Teva Pharmaceuticals; 3M Shares At $14.315,2017-11-27 10:32:00-05:00,TEVA,negative
1222409.0,25 Stocks Moving In Friday's Pre-Market Session,2017-11-24 08:05:00-05:00,TEVA,neutral
1222410.0,"Teva Pharmaceutical Said to Layoff 20%-25% of Israel Workforce, Plus Few Thousand in US -Calcalist",2017-11-23 09:36:00-05:00,TEVA,neutral
1222411.0,A Look At Teva's Big Week,2017-11-17 14:27:00-05:00,TEVA,neutral
1222412.0,Teva Announces Prescription Copay Savings Program for Generic Gleevec Tablets in the United States,2017-11-15 14:19:00-05:00,TEVA,positive
1222413.0,Teva Gets A Boost From Apollo Stake,2017-11-15 13:26:00-05:00,TEVA,positive
1222414.0,"13F Filing From Apollo Management Shows New Stake In Macy's and Teva Pharmaceuticals, Reduced Stake In Tesla, Norwegian Cruise Lines and Weatherford",2017-11-14 16:09:00-05:00,TEVA,neutral
1222415.0,"For Teva Pharmaceuticals, No Recovery In Sight, Says Analyst",2017-11-13 12:48:00-05:00,TEVA,negative
1222416.0,"Citigroup Maintains Neutral on Teva Pharmaceutical Industries Ltd, Lowers Price Target to $13.00",2017-11-13 12:06:00-05:00,TEVA,negative
1222417.0,"Benzinga's Top Upgrades, Downgrades For November 13, 2017",2017-11-13 09:36:00-05:00,TEVA,positive
1222418.0,"The Market In 5 Minutes: GE's New Road Map, SportsCenter On Snapchat, Teva Downgrade",2017-11-13 08:11:00-05:00,TEVA,neutral
1222419.0,A Peek Into The Markets: U.S. Stock Futures Signal Lower Start On Wall Street,2017-11-13 07:02:00-05:00,TEVA,negative
1222420.0,JP Morgan Downgrades Teva Pharmaceutical Industries Ltd to Underweight,2017-11-13 06:27:00-05:00,TEVA,positive
1222421.0,"Pharma Stock Roundup: Pfizer, Teva, Novartis, And More",2017-11-06 12:19:00-05:00,TEVA,neutral
1222422.0,TEVA Option Alert: Jan 19 $12.5 Puts Sweep (27) at the Bid: 675 @ $1.301 vs 5986 OI; Ref=$12.205,2017-11-06 11:58:00-05:00,TEVA,positive
1222423.0,"Teva Shares Up 8% Following Sun. Article From Israel's Globes 'Len Blavatnik mulls stake in Teva'; Stock Fell ~20% Nov. 2 Following Q3 Miss, Lowered FY17 Guidance",2017-11-06 10:55:00-05:00,TEVA,neutral
1222424.0,"Credit Suisse Lowers Price Target On Teva Pharmaceuticals From $14 to $8 Citing Recent Guidance Cut, Saying Firm Expects To 'Languish' Near-Term",2017-11-06 09:26:00-05:00,TEVA,neutral
1222425.0,TEVA Option Alert: Mar 16 $10 Puts Sweep (24) at the Bid: 673 @ $0.921 vs 10488 OI; Ref=$11.335,2017-11-03 12:26:00-04:00,TEVA,positive
1222426.0,"Analyst Eats 'Some Humble Pie,' Says Teva Needs To Deliver On Greater Visibility In Coming Months",2017-11-03 11:09:00-04:00,TEVA,positive
1222427.0,"Morgan Stanley Cuts Teva Pharmaceuticals Price Target From $14 to $7 On Competitve Risk, Potential Dividend Cut Early Next Year",2017-11-03 09:19:00-04:00,TEVA,negative
1222428.0,"Benzinga's Top Upgrades, Downgrades For November 3, 2017",2017-11-03 09:10:00-04:00,TEVA,positive
1222429.0,Deutsche Bank Downgrades Teva Pharmaceutical Industries Ltd to Hold,2017-11-03 07:15:00-04:00,TEVA,neutral
1222430.0,66 Biggest Movers From Yesterday,2017-11-03 04:49:00-04:00,TEVA,neutral
1222431.0,Neurocrine Biosciences Exceeds Expectations With Ingrezza Launch,2017-11-02 13:48:00-04:00,TEVA,neutral
1222432.0,"Teva Highlights Closing Of Plan B One-Step Sale; Says Continues To Progress, Actively Pursue Added Divestiture Opportunities, Including Previously Announced Deal With CVC, Sees Generating At Least $2.3B In Proceeds From Sales",2017-11-02 13:18:00-04:00,TEVA,positive
1222433.0,52 Stocks Moving In Thursday's Mid-Day Session,2017-11-02 12:29:00-04:00,TEVA,neutral
1222434.0,Teva Tumbles,2017-11-02 12:00:00-04:00,TEVA,neutral
1222435.0,Seeing Notable Block Trade In Teva Pharmaceuticals; 1M Shares At $11.165,2017-11-02 09:53:00-04:00,TEVA,negative
1222436.0,11 Technical Levels Discussed On Thursday's PreMarket Prep,2017-11-02 09:51:00-04:00,TEVA,neutral
1222437.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-11-02 08:25:00-04:00,TEVA,neutral
1222438.0,A Peek Into The Markets: U.S. Stock Futures Edge Lower; All Eyes On Apple Earnings,2017-11-02 07:41:00-04:00,TEVA,negative
1222439.0,"Teva Lowers FY17 Sales From $22.8-$23.2B To $22.2-$22.3B, Adj. EPS Lowered From $4.30-$4.50 To $3.77-$3.87 Est.",2017-11-02 07:08:00-04:00,TEVA,negative
1222440.0,Teva Lowers FY17 Guidance,2017-11-02 07:08:00-04:00,TEVA,negative
1222441.0,"Teva Reports Q3 EPS $1.00 vs $1.04 Est., Sales $5.6B vs $5.62B Est.",2017-11-02 07:07:00-04:00,TEVA,neutral
1222442.0,"Earnings Scheduled For November 2, 2017",2017-11-02 05:08:00-04:00,TEVA,neutral
1222443.0,"UPDATE: Neos Says 'evaluating the paragraph IV certification and intends to vigorously enforce its intellectual property rights relating to Cotempla XR-ODT,' Has 45 Days From Receipt Of Paragraph IV To Begin Suit",2017-11-01 08:12:00-04:00,TEVA,positive
1222444.0,"UPDATE: Neos Paragraph IV From Teva Shows Allegations '3 U.S. patents listed in the FDA's Orange Book for Cotempla, 1 with an expiration date in Apr. '26, 2 with expiration dates in June 2032, will not be  infringed by Teva's proposed product'",2017-11-01 08:11:00-04:00,TEVA,neutral
1222445.0,Neos Therapeutics 8-K Shows Co. Received Paragraph IV Certification From Teva Advising Co. That Teva Has Submitted ANDA For Generic Version Of Cotempla XR-ODT,2017-11-01 08:09:00-04:00,TEVA,neutral
1222446.0,Is A Turnaround In Store For Teva In Q3 Earnings?,2017-10-31 12:35:00-04:00,TEVA,neutral
1222447.0,Teva Shares Largely Unaffected Following Report State Attorney Generals Have Expanded Suit Alleging Price Fixing By Generic Drugmakers; Stock Up 2.4% For Session,2017-10-31 10:48:00-04:00,TEVA,positive
1222448.0,"Watching Healthcare, Biotech Stocks, ETFs Amid Report Attorney Generals From 46 States Will Expand Suit Related To Alleged Price Fixing Among Generic Drugmakers to 18 Cos., 15 Medicines",2017-10-31 10:46:00-04:00,TEVA,positive
1222449.0,"Teva Wins Generic Uceris Patent Trial , Says Teva's Drug Did Not Meet Threshold To Establish Infringement",2017-10-31 09:53:00-04:00,TEVA,positive
1222450.0,Teva Names Kare Schultz CEO Effective Nov. 1,2017-10-30 16:27:00-04:00,TEVA,positive
1222451.0,22 Stocks To Watch After President Trump Declares Opioid Epidemic A National Health Emergency,2017-10-26 15:24:00-04:00,TEVA,negative
1222452.0,Mylan Wins UK Court Ruling Related to Copaxone 40 mg/mL Patent,2017-10-26 05:59:00-04:00,TEVA,positive
1222453.0,Benzinga's Option Alert Recap From October 25,2017-10-25 16:35:00-04:00,TEVA,positive
1222454.0,TEVA Option Alert: Nov 3 $13.5 Puts Sweep (27) at the Bid: 2154 @ $0.43 vs 781 OI; Ref=$13.8839,2017-10-25 12:51:00-04:00,TEVA,positive
1222455.0,Federal Prosecutors In Conneticut Began A Criminal Investigation Into Purdue Pharma,2017-10-25 12:48:00-04:00,TEVA,negative
1222456.0,"Evercore Out With A Note Saying Teva Is Suing Eli Lilly, Firm Says They Found A Lawsuit Where Teva Believes Other CGRP Mabs Like Lilly Are Infringing On Its Intellectual Property",2017-10-25 11:19:00-04:00,TEVA,positive
1222457.0,TEVA Option Alert: Jan 19 $12.5 Puts at the Ask: 843 @ $0.69 vs 4251 OI; Ref=$13.98,2017-10-25 10:10:00-04:00,TEVA,positive
1222458.0,Benzinga's Option Alert Recap From October 24,2017-10-24 16:39:00-04:00,TEVA,positive
1222459.0,TEVA Option Alert: Jan 19 $27.5 Puts at the Bid: 1000 @ $13.1 vs 26046 OI; Ref=$14.3755,2017-10-24 13:47:00-04:00,TEVA,positive
1222460.0,Benzinga's Option Alert Recap From October 23,2017-10-23 16:56:00-04:00,TEVA,positive
1222461.0,TEVA Option Alert: Jan 19 $15 Puts Sweep (2) at the Ask: 500 @ $1.601 vs 22237 OI; Ref=$14.535,2017-10-23 15:52:00-04:00,TEVA,positive
1222462.0,Benzinga's Option Alert Recap From October 19,2017-10-19 16:41:00-04:00,TEVA,positive
1222463.0,Teva Pharm Option Alert: Jan 19 $17.5 Calls Sweep (2) at the Ask: 16000 @ $0.561 vs 12400 OI; Ref=$14.8,2017-10-19 13:32:00-04:00,TEVA,positive
1222464.0,Benzinga's Option Alert Recap From October 16,2017-10-16 16:34:00-04:00,TEVA,positive
1222465.0,TEVA Option Alert: Dec 1 $14 Puts Sweep (10) at the Ask: 991 @ $0.741 vs 15 OI; Ref=$14.705,2017-10-16 12:15:00-04:00,TEVA,positive
1222466.0,Teva Reaches 17-Year Low,2017-10-13 12:33:00-04:00,TEVA,negative
1222467.0,7 Stocks To Watch Ahead Of The 60 Minutes DEA-Opioid Exposé,2017-10-13 10:45:00-04:00,TEVA,neutral
1222468.0,"BioDelivery Sciences Reports Patent Litigation Settlement Agreement with Teva, BDSI Enters Non-Exclusive Licensing Agreement With Teva That Permits Teva To Begin Selling A Generic In July 2028, Other Terms Not Disclosed",2017-10-12 07:02:00-04:00,TEVA,positive
1222469.0,"Teva To Report Q3 Earnings On Thurs., Nov. 2 Before Market Open",2017-10-10 13:46:00-04:00,TEVA,neutral
1222470.0,Life (Science) Lessons: The Hows And Whos To Play Biotech,2017-10-06 11:09:00-04:00,TEVA,positive
1222471.0,"Teva Pharmaceuticals Responds To Patent Office Decision In Eli Lilly's Favor, Tells Benzinga: 'We are disappointed with the court's decision and evaluating our options to appeal'",2017-10-06 08:59:00-04:00,TEVA,negative
1222472.0,Eli Lilly Shares Spike On Patent Victory,2017-10-05 17:07:00-04:00,TEVA,positive
1222473.0,Teva Shares Plummet After Mylan's Copaxone Generic Gets FDA Approval,2017-10-05 12:08:00-04:00,TEVA,positive
1222474.0,Momenta Pharma Could Face Pressure Following Approval Of Mylan's Generic Copaxone,2017-10-05 08:58:00-04:00,TEVA,positive
1222475.0,"Jim Cramer Advises His Viewers On Teva, AT&T And More",2017-10-05 07:51:00-04:00,TEVA,neutral
1222476.0,Benzinga's Option Alert Recap From October 4,2017-10-04 16:22:00-04:00,TEVA,positive
1222477.0,"Mylan And Teva And Copaxone, Explained",2017-10-04 14:35:00-04:00,TEVA,neutral
1222478.0,18 Biggest Mid-Day Losers For Wednesday,2017-10-04 12:38:00-04:00,TEVA,negative
1222479.0,"Mylan's Generic Copaxone Arrives, Teva Sales To Take A Hit",2017-10-04 11:40:00-04:00,TEVA,neutral
1222480.0,TEVA Option Alert: Fri $17 Puts Sweep (7) at the Bid: 891 @ $0.76 vs 786 OI; Ref=$16.5501,2017-10-04 09:37:00-04:00,TEVA,positive
1222481.0,"Pre-Market Imbalance Update: Teva 224K Shares To Sell, GM 83K To Sell, GE 248K Shares To Buy, Bank of America 123 Shares to Buy",2017-10-04 09:14:00-04:00,TEVA,positive
1222482.0,Why Is Teva Falling? Competition,2017-10-04 09:10:00-04:00,TEVA,negative
1222483.0,What Approval For Generic Copaxone Means For Mylan,2017-10-04 08:27:00-04:00,TEVA,positive
1222484.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-10-04 08:07:00-04:00,TEVA,neutral
1222485.0,Teva Shares Down 16% Premarket Following FDA Approval Of Mylan's Copaxone,2017-10-04 07:51:00-04:00,TEVA,positive
1222486.0,The Market In 5 Minutes: The Market Wakes Up To The Trump Tax Plan,2017-09-28 08:25:00-04:00,TEVA,neutral
1222487.0,Teva Runs Out Of Buyers After Changes In C-Suite,2017-09-27 14:37:00-04:00,TEVA,neutral
1222488.0,Teva Pharma Announces Reintroduction Of Generic Depo-Provera In The U.S.,2017-09-25 14:29:00-04:00,TEVA,neutral
1222489.0,"Teva Shares Fall At Open, Down ~0.9%; Seeing Notable Put Activity At The Nov $17.50 Contract: Volume Of ~6,330 Contracts vs Open Interest Of ~3,500 Contracts",2017-09-21 09:39:00-04:00,TEVA,positive
1222490.0,"UPDATE: NY AG Schneiderman Served Subpoenas To Endo Int'l, J&J's Janssen Pharma, Teva, Allergan",2017-09-19 12:35:00-04:00,TEVA,neutral
1222491.0,Teva Reports  Sale of Remaining Assets in Specialty Global Women's Health Portfolio for $1.38B To CVC Capital Partners Fund VI,2017-09-18 08:08:00-04:00,TEVA,positive
1222492.0,"Teva Shares Earlier Spiked Higher Following Mid-Day Report Co. Will Sell Its Women's Health Assets To CVC Capital, Could Be Valued At $800M; Shares Sold Off To Close Wed.'s Session",2017-09-13 16:34:00-04:00,TEVA,positive
1222493.0,"A Look At Teva's Paragard IUD Asset Sale To Cooper Companies, From Both Sides",2017-09-13 09:14:00-04:00,TEVA,positive
1222494.0,14 Biggest Mid-Day Gainers For Tuesday,2017-09-12 12:22:00-04:00,TEVA,neutral
1222495.0,"With New CEO In Place, Focus For Teva Pharma Turns To 'Execution'",2017-09-12 10:11:00-04:00,TEVA,neutral
1222496.0,22 Stocks Moving In Tuesday's Pre-Market Session,2017-09-12 08:04:00-04:00,TEVA,neutral
1222497.0,Teva Receives FDA Priority Review for First Line Use of TRI,2017-09-12 08:00:00-04:00,TEVA,neutral
1222498.0,"Wall Street's M&A Chatter From September 11: Western Digital-Toshiba, Pilgrim's Pride-Moy Park, Gigamon And More",2017-09-12 07:52:00-04:00,TEVA,neutral
1222499.0,"UPDATE: Teva Says 'continues to expect to generate at least $2 billion in total proceeds from the sale of these businesses, as well as additional asset sales to be executed by year end 2017'",2017-09-11 16:18:00-04:00,TEVA,positive
1222500.0,"Teva Says 'continues to actively pursue additional divestiture opportunities, including the sale of the remaining assets of its global Women's Health business, as well as its Oncology and Pain businesses in Europe'",2017-09-11 16:17:00-04:00,TEVA,positive
1222501.0,Teva Reports Sale Of PARAGARD To CooperSurgical For $1.1B In Cash,2017-09-11 16:15:00-04:00,TEVA,neutral
1222502.0,"A Look At Kare Schultz, The New CEO In Charge Of Teva",2017-09-11 15:59:00-04:00,TEVA,neutral
1222503.0,Mid-Afternoon Market Update: Crude Oil Up Over 1%; Alamos Gold Shares Slide,2017-09-11 14:31:00-04:00,TEVA,negative
1222504.0,The Teva Rally: Tread Carefully,2017-09-11 12:43:00-04:00,TEVA,positive
1222505.0,20 Biggest Mid-Day Gainers For Monday,2017-09-11 12:29:00-04:00,TEVA,neutral
1222506.0,Mid-Day Market Update: Dow Up 1%; Achillion Pharmaceuticals Shares Plunge,2017-09-11 12:05:00-04:00,TEVA,positive
1222507.0,Teva Pulls Back From Session Highs At $19; Hearing Raymond James Out With Cautious Comments On Name,2017-09-11 11:25:00-04:00,TEVA,negative
1222508.0,Mid-Morning Market Update: Markets Open Higher; Teva Pharmaceutical Names Kaare Schultz As CEO,2017-09-11 10:09:00-04:00,TEVA,neutral
1222509.0,"Benzinga's Top Upgrades, Downgrades For September 11, 2017",2017-09-11 09:13:00-04:00,TEVA,positive
1222510.0,Teva's New CEO Is A Positive Catalyst,2017-09-11 08:35:00-04:00,TEVA,positive
1222511.0,18 Stocks Moving In Monday's Pre-Market Session,2017-09-11 08:27:00-04:00,TEVA,neutral
1222512.0,"BTIG Research Upgrades Teva Pharmaceutical Industries Limited American Depositary Shares to Buy, Announces $24.00 Target",2017-09-11 07:47:00-04:00,TEVA,positive
1222513.0,"Teva Names Kåre Schultz as President, CEO",2017-09-11 04:05:00-04:00,TEVA,neutral
1222514.0,What Pharmaceuticals Spend On Lobbying To Influence Trump,2017-09-09 16:28:00-04:00,TEVA,negative
1222515.0,Teva Presents Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine at IHC 2017,2017-09-09 15:36:00-04:00,TEVA,positive
1222516.0,"New Mexico Said To Be Suing Johnson & Johnson, Endo, Teva, Allergan & Others Over Their Role In Opioid Drug Epidemic",2017-09-07 15:05:00-04:00,TEVA,negative
1222517.0,Shares of Teva Volatile As Traders Circulate Chatter of Activist Speculation In Stock,2017-09-01 09:51:00-04:00,TEVA,positive
1222518.0,Teva Reports FDA Approval Of AUSTEDO Tablets For Treatment Of Tardive Dyskinesia In Adults,2017-08-30 15:54:00-04:00,TEVA,positive
1222519.0,Earnings-Day Price Action A Guide To Future Price Action,2017-08-28 15:53:00-04:00,TEVA,neutral
1222520.0,"Adamas Pharma's Gocovri Approved, A Welcome Addition To Parkinson's Treatments",2017-08-25 12:03:00-04:00,TEVA,positive
1222521.0,"Playing The US Pharma Space: Buy Portola, Hold Corvus, Sell Teva",2017-08-24 13:46:00-04:00,TEVA,positive
1222522.0,The Market In 5 Minutes,2017-08-24 10:01:00-04:00,TEVA,neutral
1222523.0,5 Biggest Price Target Changes For Thursday,2017-08-24 09:44:00-04:00,TEVA,neutral
1222524.0,"Benzinga's Top Upgrades, Downgrades For August 24, 2017",2017-08-24 09:19:00-04:00,TEVA,positive
1222525.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-08-24 08:12:00-04:00,TEVA,neutral
1222526.0,A Peek Into The Markets: U.S. Stock Futures Rise; All Eyes On Jackson Hole Meeting,2017-08-24 07:00:00-04:00,TEVA,neutral
1222527.0,Credit Suisse Downgrades Teva Pharmaceutical Industries Limited American Depositary Shares to Underperform,2017-08-24 05:56:00-04:00,TEVA,positive
1222528.0,"Teva Shares Tick ~$0.15 Off Session Lows Following Report Co.'s Women's Health Unit Attracted Interest From Church & Dwight, Cooper",2017-08-22 10:16:00-04:00,TEVA,positive
1222529.0,"No Pain, No Gain: How The American Military Wants Big Pharma To Cure The Opioid Crisis",2017-08-20 10:23:00-04:00,TEVA,negative
1222530.0,Teva Reports Exclusive Launch of Generic Axiron in the United States,2017-08-18 13:39:00-04:00,TEVA,positive
1222531.0,"Democrats On House Committe On Oversight & Govt. Reform Say Launching Into MS Drug Pricing, Committee Send Letters To Biogen, Teva, Sanofi, Roche, Novartis, And Bayer",2017-08-17 11:17:00-04:00,TEVA,neutral
1222532.0,Watch These 7 Huge Put Purchases In Thursday Trade,2017-08-17 04:23:00-04:00,TEVA,positive
1222533.0,12 Biggest Mid-Day Losers For Wednesday,2017-08-16 12:59:00-04:00,TEVA,negative
1222534.0,Teva Option Alert: Sep 29 $17.5 Puts Sweep (2) at the Ask: 910 @ $1.051 vs 16 OI; Ref=$17.56,2017-08-16 11:49:00-04:00,TEVA,positive
1222535.0,"Benzinga's Top Upgrades, Downgrades For August 16, 2017",2017-08-16 09:39:00-04:00,TEVA,positive
1222536.0,Citigroup Downgrades Teva Pharmaceutical Industries Limited American Depositary Shares to Neutral,2017-08-16 07:23:00-04:00,TEVA,positive
1222537.0,"Jim Cramer Weighs In On Teva, International Paper And Inogen",2017-08-16 06:51:00-04:00,TEVA,neutral
1222538.0,The Prescription For Generic Drugs ETF,2017-08-15 08:39:00-04:00,TEVA,neutral
1222539.0,13F From Tepper's Appaloosa Shows Liquidated 2.175M Share Stake In Teva,2017-08-14 16:29:00-04:00,TEVA,positive
1222540.0,Street Has No Mercy For Teva Following Dividend Cut,2017-08-11 13:30:00-04:00,TEVA,negative
1222541.0,Jana Partners Spokesperson Tells Benzinga 'No comment' Regarding Firm Acquiring A Stake In Teva,2017-08-10 11:17:00-04:00,TEVA,negative
1222542.0,Teva Shares Volatile Following Traders Circulating Chatter That Jana Partners Is Acquiring Large Stake In The Company,2017-08-10 11:05:00-04:00,TEVA,positive
1222543.0,Seeing Notable Block Trade Of 1.1M Shares Of Teva At $18.025/Share,2017-08-09 13:20:00-04:00,TEVA,negative
1222544.0,Hearing Teva Has Said Decision Has Been Made To Initiate Potential Divestiture Of Medis Unit,2017-08-09 07:55:00-04:00,TEVA,neutral
1222545.0,18 Biggest Mid-Day Losers For Monday,2017-08-07 13:08:00-04:00,TEVA,negative
1222546.0,Mylan Price Target Slashed Even As TLD Drug Receives Tentative Approval,2017-08-07 11:56:00-04:00,TEVA,positive
1222547.0,"Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing",2017-08-07 11:55:00-04:00,TEVA,neutral
1222548.0,7 Biggest Price Target Changes For Monday,2017-08-07 10:08:00-04:00,TEVA,neutral
1222549.0,"Benzinga's Top Upgrades, Downgrades For August 7, 2017",2017-08-07 09:49:00-04:00,TEVA,positive
1222550.0,A Long Road To Recovery For Teva Pharmaceuticals; Morgan Stanley Downgrades,2017-08-07 09:28:00-04:00,TEVA,neutral
1222551.0,The Market In 5 Minutes,2017-08-07 08:45:00-04:00,TEVA,neutral
1222552.0,25 Stocks Moving In Monday's Pre-Market Session,2017-08-07 08:06:00-04:00,TEVA,neutral
1222553.0,Teva Announces FDA Approval of QVAR RediHaler,2017-08-07 08:00:00-04:00,TEVA,positive
1222554.0,Bank of Jerusalem Downgrades Teva To Market Perform,2017-08-07 07:59:00-04:00,TEVA,neutral
1222555.0,"Morgan Stanley Downgrades Teva Pharmaceutical Shares to Underweight, Lowers Price Target to $16.00",2017-08-07 06:16:00-04:00,TEVA,positive
1222556.0,Analysts Still Like Allergan,2017-08-04 14:12:00-04:00,TEVA,positive
1222557.0,25 Biggest Mid-Day Losers For Friday,2017-08-04 12:54:00-04:00,TEVA,negative
1222558.0,Teva Attempts To Bottom At March 2003 Lows,2017-08-04 12:24:00-04:00,TEVA,negative
1222559.0,Teva Loses Another Bull; Credit Suisse Downgrades,2017-08-04 12:16:00-04:00,TEVA,positive
1222560.0,"Benzinga's Top Upgrades, Downgrades For August 4, 2017",2017-08-04 09:37:00-04:00,TEVA,positive
1222561.0,The Market In 5 Minutes,2017-08-04 08:32:00-04:00,TEVA,neutral
1222562.0,Bernstein Downgrades Teva Pharmaceutical Industries Limited American Depositary Shares to Market Perform,2017-08-04 08:17:00-04:00,TEVA,positive
1222563.0,Credit Suisse Downgrades Teva Pharmaceutical Industries Limited American Depositary Shares to Neutral,2017-08-04 06:21:00-04:00,TEVA,positive
1222564.0,RBC Capital Downgrades Teva Pharmaceutical Industries Limited American Depositary Shares to Underperform,2017-08-04 06:18:00-04:00,TEVA,positive
1222565.0,Cowen & Co. Downgrades Teva Pharmaceutical Industries Limited American Depositary Shares to Market Perform,2017-08-04 06:17:00-04:00,TEVA,positive
1222566.0,Teva Downgraded As Analyst Casts Doubt On Turnaround Story,2017-08-03 13:19:00-04:00,TEVA,negative
1222567.0,25 Biggest Mid-Day Losers For Thursday,2017-08-03 13:02:00-04:00,TEVA,negative
1222568.0,Teva's Stock At Lowest Level Since November 2004,2017-08-03 12:38:00-04:00,TEVA,negative
1222569.0,Mid-Day Market Update: Stamps.com Surges On Earnings Beat; Aerohive Shares Plunge,2017-08-03 12:08:00-04:00,TEVA,positive
1222570.0,"Teva's Quarter: Earnings Miss, Guidance Cut, Dividend Devastated",2017-08-03 10:29:00-04:00,TEVA,negative
1222571.0,Oppenheimer Downgrading Teva As They No Longer See A Clear Path To Return To Growth in A Timely Manner And Cont. Pricing Pressure In U.S. Generics Makes Firm Less Optimistic That Its U.S. Generics Business Will Meet Or Exceed Street's Expectations In 2H17,2017-08-03 09:57:00-04:00,TEVA,positive
1222572.0,Oppenheimer Downgrades Teva Pharmaceutical Industries Limited American Depositary Shares to Perform,2017-08-03 09:56:00-04:00,TEVA,positive
1222573.0,"Teva Pharmaceuticals Shares Down 17% Pre-Market Following Q2 Miss, Reduced Outlook, Dividend",2017-08-03 09:17:00-04:00,TEVA,positive
1222574.0,Teva Cuts Qtr. Dividend From $0.34 To $0.085/Share,2017-08-03 08:17:00-04:00,TEVA,negative
1222575.0,22 Stocks Moving In Thursday's Pre-Market Session,2017-08-03 08:07:00-04:00,TEVA,neutral
1222576.0,"UPDATE: Teva Cuts FY17 Adj. EPS Outlook From $4.90-$5.30 To $4.30-$4.50 vs $4.74 Est., Sales From $23.8B-$24.5B To $22.8B-$23.2B vs $23.4B Est.",2017-08-03 06:33:00-04:00,TEVA,negative
1222577.0,Teva Cuts FY17 Outlook,2017-08-03 06:32:00-04:00,TEVA,negative
1222578.0,"Teva Reports Q2 Adj. EPS $1.02 vs $1.06 Est., Sales $5.7B vs $5.72B Est.",2017-08-03 06:32:00-04:00,TEVA,neutral
1222579.0,"Earnings Scheduled For August 3, 2017",2017-08-03 04:10:00-04:00,TEVA,neutral
1222580.0,"Celltrion, Teva Report U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar to Herceptin",2017-07-31 08:05:00-04:00,TEVA,positive
1222581.0,Teva Reports Launch Of Generic Epiduo In US,2017-07-28 08:03:00-04:00,TEVA,neutral
1222582.0,Teva Reports Launch of Generic Epiduo in the United States,2017-07-28 08:00:00-04:00,TEVA,positive
1222583.0,Watch These 5 Huge Put Purchases In Friday Trade,2017-07-28 04:08:00-04:00,TEVA,positive
1222584.0,Benzinga's Option Alert Recap From July 27,2017-07-27 16:05:00-04:00,TEVA,positive
1222585.0,TEVA Option Alert: Aug 4 $34 Puts Sweep (9) at the Bid: 520 @ $1.49 vs 0 OI; Ref=$32.79,2017-07-27 11:04:00-04:00,TEVA,positive
1222586.0,AstraZeneca CEO Declines Comment on Reports He is Leaving to Join Teva -Reuters,2017-07-27 04:14:00-04:00,TEVA,positive
1222587.0,Teva Reports the Launch of Generic Vagifem in the United States,2017-07-24 14:51:00-04:00,TEVA,positive
1222588.0,Teva +1.1% Premarket @$32.27 After Report NICE Recommends CINQAERO for Treatment of Severe Eosinophilic Asthma,2017-07-20 08:41:00-04:00,TEVA,positive
1222589.0,"AstraZeneca CEO Rumor Reportedly Ends, Shares Rise",2017-07-18 13:34:00-04:00,TEVA,positive
1222590.0,The Market In 5 Minutes,2017-07-17 08:57:00-04:00,TEVA,neutral
1222591.0,EU Antitrust Regulators Charge Teva with doing 'Pay-for-Delay' Deal with Cephalon Over Sleep Disorder Drug,2017-07-17 06:11:00-04:00,TEVA,negative
1222592.0,The Market In 5 Minutes,2017-07-14 09:05:00-04:00,TEVA,neutral
1222593.0,AstraZeneca Declines Comment on Report CEO is Leaving Co -Reuters,2017-07-14 04:41:00-04:00,TEVA,neutral
1222594.0,Watch These 7 Huge Call Purchases In Friday Trade,2017-07-14 04:01:00-04:00,TEVA,positive
1222595.0,Analyst Wonders If AstraZeneca's CEO Would Be A Fit At Teva,2017-07-13 17:08:00-04:00,TEVA,positive
1222596.0,Benzinga's Option Alert Recap From July 13,2017-07-13 16:48:00-04:00,TEVA,positive
1222597.0,"Credit Suisse's Divan On Impact To Teva If AstraZeneca CEO Joins Co.: 'I think it is probably a net-neutral impact, maybe net positive.'",2017-07-13 16:38:00-04:00,TEVA,positive
1222598.0,"Credit Suisse's Divan On AstraZeneca CEO Soriot Fitting Into Teva Leadership: '[If Teva decides to keep Generics] as the core of the business going forward, I would have to wonder if he is the best fit'",2017-07-13 16:37:00-04:00,TEVA,positive
1222599.0,"Credit Suisse Analyst Vamil Divan Tells Benzinga He's Leaning Toward Believing Calcalist's Original Report Of Teva Hiring AstraZeneca's CEO, Notes Calcalist Broke News Of Teva CFO Leaving Co.; Past Report Gives Him Some Sense Of Credibility",2017-07-13 16:26:00-04:00,TEVA,positive
1222600.0,Teva Spokesperson Declines Comment Following Calcalist Report Co. Could Hire AstraZeneca CEO Soriot,2017-07-13 12:43:00-04:00,TEVA,neutral
1222601.0,Teva Board Approves All Proposals At Annual Shareholder Meeting,2017-07-13 11:43:00-04:00,TEVA,positive
1222602.0,TEVA Option Alert: Jul 21 $34 Calls Sweep (3) at the Ask: 3633 @ $0.281 vs 569 OI; Ref=$33.07,2017-07-13 09:40:00-04:00,TEVA,positive
1222603.0,Teva Shares Up 2.2% Following News Of The Company Could Hire AstraZenneca CEO Soriot,2017-07-13 08:54:00-04:00,TEVA,positive
1222604.0,Hearing Teva Will Hearing AstraZeneca CEO Soriot,2017-07-12 15:18:00-04:00,TEVA,neutral
1222605.0,"Teva, Huntington Study Group Offer Data For AUSTEDO Tablets In Huntington Disease: 'Data support overnight conversion from tetrabenazine to AUSTEDO™ for the treatment of chorea associated with Huntington disease'",2017-07-11 08:03:00-04:00,TEVA,positive
1222606.0,Kitov Pharmaceuticals Says on July 6 Named Gil Ben-Menachem to Fill Vacancy on Board,2017-07-07 07:25:00-04:00,TEVA,neutral
1222607.0,Najarian Brothers See Unusual Options Activity In Energy Transfer Equity And Teva Pharmaceutical,2017-07-06 06:46:00-04:00,TEVA,positive
1222608.0,"Celltrion, Teva Announce U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar to Rituxan",2017-06-29 08:30:00-04:00,TEVA,positive
1222609.0,Teva Reports Publication of AIM-TD Study Results in The Lancet Psychiatry for the Investigational Use of Deutetrabenazine in Tardive Dyskinesia,2017-06-29 08:03:00-04:00,TEVA,neutral
1222612.0,"UPDATE: Xenon Pres, CEO, Simon Pimstone, Says '...Xenon remains focused on advancing its pipeline of neurology-related development candidates, with multiple programs anticipated to enter clinical development in 2017'",2017-06-27 08:16:00-04:00,TEVA,positive
1222613.0,"Teva, Xenon Pharma Report Results From Phase II Study Of TV-45070 In Patients With PHN: Did Not Meet Primary, Secondary Endpoints",2017-06-27 08:16:00-04:00,TEVA,neutral
1222614.0,"Benzinga's Top Upgrades, Downgrades For June 16, 2017",2017-06-16 09:35:00-04:00,TEVA,positive
1222615.0,The Market In 5 Minutes,2017-06-16 09:08:00-04:00,TEVA,neutral
1222616.0,"Mizuho Upgrades Teva Pharmaceutical Industries Limited American Depositary Shares to Neutral, Raises Price Target to $30.00",2017-06-15 17:24:00-04:00,TEVA,positive
1222617.0,"Cantor Fitzgerald Reportedly Initiates Coverage On Teva Pharmaceutical Industrieswith Neutral Rating, Announces $31.00 Price Target",2017-06-15 17:23:00-04:00,TEVA,neutral
1222618.0,Teva Shares Tick Higher In After-Hours Action As Hearing Mizuho Upgraded To Neutral,2017-06-15 16:07:00-04:00,TEVA,positive
1222619.0,Teva Pharmaceuticals Initiates Voluntary Recall To Retail-Lvel For One Lot Of Paliperidone ER Tablets,2017-06-15 12:03:00-04:00,TEVA,neutral
1222622.0,"Jim Cramer Weighs In On Under Armour, Walgreens And Teva Pharmaceutical",2017-06-14 06:11:00-04:00,TEVA,neutral
1222624.0,Teva Reports Launch of Generic Zetia in the United States,2017-06-12 15:19:00-04:00,TEVA,positive
1222625.0,Teva Reports Exclusive Launch of Generic Pataday in the U.S.,2017-06-09 08:54:00-04:00,TEVA,positive
1222627.0,"Mylan Earlier Issued Proxy Statements Disclosing Letter to ISS, Shows 'As we have repeatedly stated, Teva never made an offer to acquire Mylan'",2017-06-07 08:33:00-04:00,TEVA,neutral
1222628.0,"Jefferies Health Care Conference Continues Today, Presenters Include Teva, WAVE Life Sciences, Envision Healthcare, NantKwest, Ignyta, Puma Biotech, and Kite Pharma",2017-06-07 08:23:00-04:00,TEVA,positive
1222629.0,"Teva Reports Fremanezumab Met All Primary, Secondary Endpoints",2017-06-07 08:01:00-04:00,TEVA,neutral
1222630.0,Investors Are Fleeing John Paulson's Once Hot Hedge Fund,2017-06-05 09:51:00-04:00,TEVA,neutral
1222631.0,States Are Firing Back At Opioid Drug Producers,2017-06-01 10:48:00-04:00,TEVA,negative
1222632.0,"Shares Of Johnons & Johnson, Teva Pharma, Endo Int'l, And Allergan All Higher Today Despite News State Of Ohio Has Sued These Companies For Alleged Role In Opioid Epidemic",2017-05-31 12:59:00-04:00,TEVA,positive
1222633.0,"Oppenheimer on Teva Following Study Results for Fremanezumab: News is a 'Nice Positive' for Co. 'Given Recent Mgmt Departures, Turmoil Within Generic Business'",2017-05-31 12:25:00-04:00,TEVA,positive
1222634.0,"Teva Announces Phase III Study of Fremanezumab Met All Primary, Secondary Endpoints In Both Monthly & Quarterly Dosing Regimens",2017-05-31 08:22:00-04:00,TEVA,neutral
1222635.0,Teva Pharmaceuticals Gain FDA Approval To Market First Generic Versions Of Strattera,2017-05-30 16:20:00-04:00,TEVA,positive
1222636.0,"It's Easy To Be Skeptical Of Mylan, But Don't Ignore This Pending PDUFA Date",2017-05-22 12:25:00-04:00,TEVA,positive
1222637.0,Vetr Issues Strong Buy As Teva Trends Down,2017-05-19 07:30:00-04:00,TEVA,positive
1222638.0,Teva Reports Launch Of Generic Glumetza In U.S.,2017-05-15 13:24:00-04:00,TEVA,neutral
1222639.0,"Otsuka, Teva Sign Licensing Agreement for Japan on Prophylactic Migraine Drug Candidate Fremanezumab; Otsuka To Pay Teva A Lump-Sum Payment of $50M",2017-05-15 08:03:00-04:00,TEVA,positive
1222640.0,"Otsaka Pharma, Teva Report Deal Covering Japan for Otsuka to Develop, Commercialize Teva's TEVA-48125 for Prevention of Migraine",2017-05-15 08:00:00-04:00,TEVA,neutral
1222641.0,Appaloosa Lowers Stake In Teva Pharmaceuticals,2017-05-12 16:17:00-04:00,TEVA,negative
1222642.0,5 Biggest Price Target Changes For Friday,2017-05-12 09:49:00-04:00,TEVA,neutral
1222643.0,"Teva Interim CEO Says Headcount Reduced By 5K Since Actavis Deal, More Cuts Expected by End of 2017 -Reuters",2017-05-11 08:13:00-04:00,TEVA,negative
1222644.0,A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Macy's Earnings,2017-05-11 07:45:00-04:00,TEVA,neutral
1222645.0,"Teva Reports Q1 Adj. EPS $1.06 vs $1.03 Est., Sales $5.6B vs $5.68B Est.",2017-05-11 07:30:00-04:00,TEVA,neutral
1222646.0,Teva +3.5% Premarket @$32.46 Following Earnings Report,2017-05-11 07:26:00-04:00,TEVA,neutral
1222647.0,"10 Stocks To Watch For May 11, 2017",2017-05-11 05:08:00-04:00,TEVA,neutral
1222648.0,"Earnings Scheduled For May 11, 2017",2017-05-11 04:32:00-04:00,TEVA,neutral
1222649.0,Teva Shares Down ~2.5% Over Last Few Mins,2017-05-10 10:24:00-04:00,TEVA,positive
1222650.0,"Prestige Brands Seen As A Prime Takeout Candidate On Cash Flow Strength, Earnings Growth",2017-05-09 10:09:00-04:00,TEVA,positive
1222651.0,"Teva Pharma, Active Biotech Reports CONCERTO Trial of Laquinimod in RRMS Did Not Meet Primary Endpoint",2017-05-05 14:03:00-04:00,TEVA,positive
1222652.0,Benzinga's Option Alert Recap From May 3,2017-05-03 16:52:00-04:00,TEVA,positive
1222653.0,Option Alert: TEVA May 34.0 Calls Sweep: 1123 @  ASK  $0.12: 1123 traded vs 867 OI:  Earnings 5/11 Before Open  $30.85 Ref,2017-05-03 11:02:00-04:00,TEVA,positive
1222654.0,Benzinga's Option Alert Recap From May 2,2017-05-02 16:55:00-04:00,TEVA,positive
1222655.0,Option Alert: TEVA May 12th 31.0 Puts: 1964 @  ASK  $0.63: 3050 traded vs 3127 OI:  Earnings 5/11 Before Open  $31.50 Ref,2017-05-02 10:00:00-04:00,TEVA,positive
1222656.0,Teva Announces Launch of Generic Vytorin In U.S.,2017-04-26 16:09:00-04:00,TEVA,neutral
1222657.0,Teva Announces CFO Eyal Desheh To Step Down,2017-04-26 09:06:00-04:00,TEVA,neutral
1222658.0,Teva Considers Sale of Cancer Portfolio -Bloomberg,2017-04-26 06:28:00-04:00,TEVA,negative
1222659.0,Watch These 8 Huge Call Purchases In Wednesday Trade,2017-04-26 04:04:00-04:00,TEVA,positive
1222660.0,Benzinga's Option Alert Recap From April 25,2017-04-25 17:12:00-04:00,TEVA,positive
1222661.0,Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates,2017-04-25 13:44:00-04:00,TEVA,positive
1222662.0,Option Alert: TEVA Dec17 30.0 Calls Sweep: 839 @  ASK  $3.099: 2000 traded vs 0 OI:  Earnings 5/11 Before Open  $30.72 Ref,2017-04-25 11:52:00-04:00,TEVA,positive
1222663.0,Teva Aiming to Resume Some Production at Rimsa Plant in Mexico -Reuters,2017-04-25 07:25:00-04:00,TEVA,neutral
1222664.0,Teva Launches AirDuo RespiClick And Its Authorized Generic,2017-04-20 08:42:00-04:00,TEVA,neutral
1222665.0,6-K from Teva Shows Co. Received Warning Letter from FDA Related to cGMP Inspection for API Manufacturing Facility in China,2017-04-13 08:28:00-04:00,TEVA,negative
1222666.0,"Approval For Neurocrine's Ingrezza Was No Surprise, But Lack Of Warning Label A Big Advantage Over Teva",2017-04-12 13:40:00-04:00,TEVA,negative
1222667.0,Neurocrine Outperforms Even Bullish Estimates Of Ingrezza Approval Upside,2017-04-12 12:57:00-04:00,TEVA,positive
1222668.0,Adam Feuerstein Tweets: $NBIX says no black box safety warning for Ingrezza. That's an added positive in competitive fight against $TEVA.,2017-04-11 17:01:00-04:00,TEVA,positive
1222669.0,Benzinga's Option Alert Recap From April 7,2017-04-07 16:30:00-04:00,TEVA,positive
1222670.0,Trader's Attributing Strength In Teva To Chatter Co. Exploring Sale of Women's Health Division For Up To $2B,2017-04-07 13:52:00-04:00,TEVA,positive
1222671.0,Option Alert: TEVA Apr 13th 34.5 Calls Sweep: 887 @  ASK  $0.06: 887 traded vs 40 OI:  Earnings 5/11 Before Open  $32.27 Ref,2017-04-07 13:52:00-04:00,TEVA,positive
1222672.0,"Teva Shares Spike Higher, Still Down ~0.4%, Following Report of Fresenius Interest in Generic Maker, Akorn",2017-04-07 13:07:00-04:00,TEVA,positive
1222673.0,Teva Announces FDA Approval Of AUSTEDO,2017-04-03 17:04:00-04:00,TEVA,positive
1222674.0,Alan Knuckman's Teva Trade,2017-04-01 11:05:00-04:00,TEVA,neutral
1222675.0,Benzinga's Option Alert Recap From March 24,2017-03-24 16:15:00-04:00,TEVA,positive
1222676.0,Option Alert: TEVA Mar 31st 34.0 Calls Sweep: 750 @  ASK  $0.08: 803 traded vs 536 OI:  Earnings 5/11 Before Open  $32.54 Ref,2017-03-24 11:41:00-04:00,TEVA,positive
1222677.0,Teva's Stock Inches Higher Amid Cost-Cutting Plan,2017-03-23 08:19:00-04:00,TEVA,neutral
1222678.0,Teva Announces Launch of Authorized Generic Of Minastrin In The U.S.,2017-03-16 13:58:00-04:00,TEVA,neutral
1222679.0,"Barclays Global Healthcare Conference Continues Today; Presenters Include HCA Holdings, Valeant, Incyte, Celgene, Cotiviti, Aetna, Anthem, Seattle Genetics, Teva Pharma, Pfizer, & Bristol-Myers",2017-03-15 08:25:00-04:00,TEVA,neutral
1222680.0,Watch These 8 Huge Put Purchases In Thursday Trade,2017-03-09 04:44:00-05:00,TEVA,positive
1222681.0,Benzinga's Option Alert Recap From March 8,2017-03-08 17:51:00-05:00,TEVA,positive
1222682.0,Option Alert: Teva Jan18 30.0 Puts: 4500 @  ASK  $2.56: 5005 traded vs 21k OI:  Earnings 5/8 Before Open (est)  $33.14 Ref,2017-03-08 10:33:00-05:00,TEVA,positive
1222683.0,"Cowen Annual Healthcare Conference Concludes Today; Presenters Include Agilent Tech, Incyte, GW Pharma, Teva Pharma, NantKwest, Seattle Genetics, And Celgene",2017-03-08 08:25:00-05:00,TEVA,neutral
1222684.0,"Appaloosa's David Tepper On CNBC Says Teva Was Not The Best Position, 'Screwed the pooch'; Some Days He Thinks It's So Cheap He Should Buy More And Other Days He Doesn't Know Why It's On His Book",2017-03-08 07:54:00-05:00,TEVA,negative
1222685.0,9 Stocks That Retail Investors Loved in February,2017-03-07 12:54:00-05:00,TEVA,positive
1222686.0,TD Ameritrade's Investor Movement Index (IMX) For February 2017,2017-03-06 12:49:00-05:00,TEVA,neutral
1222687.0,Teva Reports Launch of Generic Pristiq in the United States,2017-03-01 10:56:00-05:00,TEVA,positive
1222688.0,"Analyst Says Teva Is 'Plagued With Problems,' Downgrades On Challenging Outlook",2017-02-28 09:06:00-05:00,TEVA,positive
1222689.0,Teva Reports FDA Priority Review Granted for SD-809 for Treatment of Tardive Dyskinesia,2017-02-28 08:04:00-05:00,TEVA,positive
1222690.0,Argus Downgrades Teva Pharmaceutical Industries To Hold,2017-02-28 07:22:00-05:00,TEVA,neutral
1222691.0,Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market',2017-02-23 14:06:00-05:00,TEVA,positive
1222692.0,"Oppenheimer Says Momenta's Delay Of Generic Copaxone 40mg A Modest Positive For Teva, Says There Remains Risk Of Generic 40mg Approval From Other Generic Filers",2017-02-21 07:50:00-05:00,TEVA,positive
1222693.0,Credit Suisse Says That The Delay In Momenta's Glatopa 40MG Is A Surprising Positive For Teva,2017-02-21 07:48:00-05:00,TEVA,positive
1222694.0,"13F from Tepper's Appaloosa Shows New Stakes in Mylan, Pfizer, Teva",2017-02-14 16:19:00-05:00,TEVA,neutral
1222695.0,The Market In 5 Minutes,2017-02-14 09:29:00-05:00,TEVA,neutral
1222696.0,Risks For Teva Remain As CEO Search Continues,2017-02-14 08:14:00-05:00,TEVA,negative
1222697.0,Mid-Afternoon Market Update: Dow Rises 150 Points; Zeltiq Aesthetics Shares Surge Following Acquisition News,2017-02-13 14:58:00-05:00,TEVA,positive
1222698.0,Q4 2016 Real-Time Call Brief,2017-02-13 12:39:00-05:00,TEVA,neutral
1222699.0,18 Biggest Mid-Day Gainers For Monday,2017-02-13 12:30:00-05:00,TEVA,neutral
1222700.0,Mid-Day Market Update: Crude Oil Down Around 2%; Zosano Pharma Shares Spike Higher,2017-02-13 12:00:00-05:00,TEVA,negative
1222701.0,Teva Surrenders Some Early Gains After Q4 Beat,2017-02-13 11:40:00-05:00,TEVA,positive
1222702.0,Traders Attributing Recent Strength In Teva To Rumor That Co. Is Weighing Options For Units Including Its Branded Generics Business,2017-02-13 11:36:00-05:00,TEVA,positive
1222703.0,Mid-Morning Market Update: Markets Open Higher; Teva Tops Q4 Estimates,2017-02-13 10:13:00-05:00,TEVA,positive
1222704.0,The Market In 5 Minutes: Hello... Can You Hear Me?,2017-02-13 09:29:00-05:00,TEVA,neutral
1222705.0,18 Stocks Moving In Monday's Pre-Market Session,2017-02-13 08:44:00-05:00,TEVA,neutral
1222706.0,"Teva Gets Actavis Boost, Q4 Results Top Estimates",2017-02-13 08:44:00-05:00,TEVA,positive
1222707.0,"Teva Pharma Sees FY 2017 EPS $4.90 to $5.30 vs $4.83 Est, Revenue $23.8B to $24.5B vs $23.7B Est",2017-02-13 06:44:00-05:00,TEVA,neutral
1222708.0,"Teva Pharma Q4 EPS $1.38 vs $1.35 Est, Revenue $6.49B vs $6.25B Est",2017-02-13 06:43:00-05:00,TEVA,neutral
1222709.0,7 Stocks You Should Be Watching Today,2017-02-13 05:50:00-05:00,TEVA,neutral
1222710.0,"Earnings Scheduled For February 13, 2017",2017-02-13 05:15:00-05:00,TEVA,neutral
1222711.0,7 Biggest Price Target Changes For Friday,2017-02-10 10:14:00-05:00,TEVA,neutral
1222712.0,"Benzinga's Top Upgrades, Downgrades For February 10, 2017",2017-02-10 09:32:00-05:00,TEVA,positive
1222713.0,"Mizuho Downgrades Teva Pharmaceutical To Underperform, Lowers Price Target To $27",2017-02-10 08:09:00-05:00,TEVA,negative
1222714.0,Teva Makes New Multi-Year Low After CEO Resignation,2017-02-07 15:33:00-05:00,TEVA,negative
1222715.0,Is Teva's 4% Dividend Yield Safe?,2017-02-07 13:42:00-05:00,TEVA,positive
